0001178913-19-000313.txt : 20190206 0001178913-19-000313.hdr.sgml : 20190206 20190206171113 ACCESSION NUMBER: 0001178913-19-000313 CONFORMED SUBMISSION TYPE: 424B5 PUBLIC DOCUMENT COUNT: 4 FILED AS OF DATE: 20190206 DATE AS OF CHANGE: 20190206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PLURISTEM THERAPEUTICS INC CENTRAL INDEX KEY: 0001158780 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 980351734 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 424B5 SEC ACT: 1933 Act SEC FILE NUMBER: 333-218916 FILM NUMBER: 19572295 BUSINESS ADDRESS: STREET 1: MATAM ADVANCED TECHNOLOGY PARK STREET 2: BUILDING NO. 5 CITY: HAIFA STATE: L3 ZIP: 31905 BUSINESS PHONE: 972-74-710-7171 MAIL ADDRESS: STREET 1: MATAM ADVANCED TECHNOLOGY PARK STREET 2: BUILDING NO. 5 CITY: HAIFA STATE: L3 ZIP: 31905 FORMER COMPANY: FORMER CONFORMED NAME: PLURISTEM LIFE SYSTEMS INC DATE OF NAME CHANGE: 20030701 FORMER COMPANY: FORMER CONFORMED NAME: AI SOFTWARE INC DATE OF NAME CHANGE: 20010906 424B5 1 zk1922547.htm 424B5
 
Filed Pursuant to Rule 424(b)(5)
Registration No. 333-218916
 
PROSPECTUS SUPPLEMENT
(to Prospectus dated June 30, 2017)
 
          
$50,000,000

Common Stock

We have entered into an Open Market Sales AgreementSM, or sales agreement, with Jefferies LLC, or Jefferies, dated February 6, 2019, relating to the sale of shares of our common stock offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the sales agreement, we may offer and sell shares of our common stock having an aggregate offering price of up to $50 million from time to time through Jefferies acting as sales agent, at our discretion.
 
Our common stock is listed on The Nasdaq Capital Market under the symbol “PSTI.” On February  5, 2019, the last reported sale price of our common stock on The Nasdaq Capital Market was $1.12 per share. Our common stock is also listed on the Tel Aviv Stock Exchange, or TASE, under the symbol “PLTR.”
 
Sales of our common stock, if any, under this prospectus supplement and the accompanying prospectus may be made in sales deemed to be “at the market offerings” as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended, or the Securities Act. Jefferies is not required to sell any specific number or dollar amount of securities but will act as a sales agent using commercially reasonable efforts consistent with its normal trading and sales practices, on mutually agreed terms between Jefferies and us. Our common stock to which this prospectus supplement relates will be sold through Jefferies on any given day. There is no arrangement for funds to be received in any escrow, trust or similar arrangement.
 
The compensation to Jefferies for sales of common stock sold pursuant to the sales agreement will be 3.0% of the gross proceeds from each such sale. In connection with the sale of the common stock on our behalf, Jefferies will be deemed to be an “underwriter” within the meaning of the Securities Act, and the compensation of Jefferies will be deemed to be underwriting commissions or discounts. We have also agreed to provide indemnification and contribution to Jefferies with respect to certain liabilities, including liabilities under the Securities Act.
   
Investing in our securities involves significant risks. Please read the information contained in or incorporated by reference under the heading “Risk Factors” beginning on page S-3 of this prospectus supplement, and under similar headings in other documents filed with the Securities and Exchange Commission and incorporated by reference into this prospectus supplement and the accompanying prospectus.
 
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.
 
Jefferies

The date of this prospectus supplement is February 6, 2019
 

TABLE OF CONTENTS
 
PROSPECTUS SUPPLEMENT
 
 
Page
S-ii
S-iii
S-1
The Offering
S-2
S-3
S-4
S-4
S-5
S-6
S-7
S-7
S-7
S-8

PROSPECTUS

 
Page
1
1
2
2
3
3
3
4
6
7
10
10
10
11

 
ABOUT THIS PROSPECTUS SUPPLEMENT
 
A registration statement on Form S-3 (File No. 333-218916) utilizing a “shelf” registration process relating to the securities described in this prospectus supplement was declared effective by the Securities and Exchange Commission, or the SEC, on June 30, 2017.  Under this “shelf” registration process, of which this offering is a part, we may, from time to time, sell our common stock, preferred stock, warrants and units.
 
This document is in two parts. The first part is this prospectus supplement, which describes the specific terms of the offering of the common stock and also adds to and updates information contained in the accompanying prospectus and the documents incorporated by reference into this prospectus supplement and the accompanying prospectus. The second part, the accompanying prospectus, including the documents incorporated by reference into the accompanying prospectus, provides more general information, some of which may not apply to this offering. Generally, when we refer to this prospectus, we are referring to the combined document consisting of this prospectus supplement and the accompanying prospectus. To the extent there is a conflict between the information contained in this prospectus supplement, on the one hand, and the information contained in the accompanying prospectus or in any document incorporated by reference into the accompanying prospectus that was filed with the SEC before the date of this prospectus supplement, on the other hand, you should rely on the information in this prospectus supplement. If any statement in one of these documents is inconsistent with a statement in another document having a later date, the statement in the document having the later date modifies or supersedes the earlier statement.
 
You should rely only on the information contained in or incorporated by reference into this prospectus supplement and the accompanying prospectus. We have not, and Jefferies has not, authorized anyone to provide you with information that is different. This prospectus supplement is not an offer to sell or solicitation of an offer to buy our securities in any circumstances under which the offer or solicitation is unlawful. We are offering to sell, and seeking offers to buy, our securities only in jurisdictions where offers and sales are permitted. You should not assume that the information we have included in this prospectus supplement or the accompanying prospectus is accurate as of any date other than the date of this prospectus supplement or the accompanying prospectus, respectively, or that any information we have incorporated by reference is accurate as of any date other than the date of the document incorporated by reference, regardless of the time of delivery of this prospectus supplement or of any of our securities. Our business, financial condition, results of operations and prospects may have changed since those dates.
 
In this prospectus supplement and the accompanying prospectus, unless otherwise indicated, the terms “Pluristem,” “we,” “us” and “our” mean Pluristem Therapeutics Inc. and its wholly-owned Israeli subsidiary, Pluristem Ltd., as required by the context.

S - ii
 
SPECIAL NOTE REGARDING FORWARD-LOOKING INFORMATION

The statements contained in this prospectus supplement, the accompanying prospectus and the documents we incorporate by reference herein or therein that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws.  Such forward-looking statements may be identified by, among other things, the use of forward-looking terminology such as “believes,” “intends,” “plans,” “expects,” “may,” “will,” “should,” or “anticipates” or the negative thereof or other variations thereon or comparable terminology, and similar expressions are intended to identify forward-looking statements.  We remind readers that forward-looking statements are merely predictions and therefore inherently subject to uncertainties and other factors and involve known and unknown risks that could cause the actual results, performance, levels of activity, or our achievements, or industry results, to be materially different from any future results, performance, levels of activity, achievements or industry results, expressed or implied by such forward-looking statements.  Such forward-looking statements include, among other statements, statements regarding the following:
 
 
·
the expected development and potential benefits from our products in treating various medical conditions;
 
 
·
the clinical trials to be conducted according to our license agreement with CHA Biotech Co. Ltd.;
 
 
·
our plan to execute our strategy independently, using our own personnel, and through relationships with research and clinical institutions or in collaboration with other companies;
 
 
·
the prospects of entering into additional license agreements, or other forms of cooperation with other companies and medical institutions;
 
 
·
our pre-clinical and clinical trials plans, including timing of initiation, enrollment and conclusion of trials;
 
 
·
achieving regulatory approvals, including under accelerated paths;
     
 
·
the expected timing of the release of data from our various studies;
 
 
·
receipt of future funding from the Israel Innovation Authority, the European Union's Horizon 2020 program and grants from other independent third parties;
 
 
·
our marketing plans, including timing of marketing our product candidates, PLX-PAD and PLX-R18;
 
 
·
developing capabilities for new clinical indications of placenta expanded (PLX) cells and new products;
     
 
·
the timing and development of our PLX-Immune product candidate;
 
 
·
our estimations regarding the size of the global market for our product candidates;
 
 
·
our expectations regarding our production capacity;
 
 
·
our expectation to demonstrate a real-world impact and value from our pipeline, technology platform and commercial-scale manufacturing capacity;
 
 
·
our expectations regarding our short- and long-term capital requirements;
 
 
·
the proposed joint venture to be established with Sosei Corporate Venture Capital Ltd. for the clinical development and commercialization of Pluristem’s PLX-PAD cell therapy product in Japan and the plan to enter into definitive agreements;
 
S - iii
 
·
our outlook for the coming months and future periods, including but not limited to our expectations regarding future revenue and expenses; and
 
 
·
information with respect to any other plans and strategies for our business.
 
The factors discussed herein, including those risks described under the heading “Risk Factors” herein, in the accompanying prospectus and in the documents we incorporate by reference could cause actual results and developments to be materially different from those expressed in or implied by such statements.  In addition, historic results of scientific research, clinical and preclinical trials do not guarantee that the conclusions of future research or trials would not suggest different conclusions.  Also, historic results referred to this prospectus supplement, the accompanying prospectus and the documents we incorporate by reference may be interpreted differently in light of additional research, clinical and preclinical trials results.  Except as required by law we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

S - iv
 
 
SUMMARY
 
This summary highlights information contained elsewhere or incorporated by reference into this prospectus supplement and the accompanying prospectus. This summary does not contain all of the information that you should consider before investing in our securities. You should carefully read the entire prospectus supplement and the accompanying prospectus, including the “Risk Factors” sections, starting on page S-3 of this prospectus supplement, page 2 of the accompanying prospectus and page 10 of our Annual Report on Form 10-K for the fiscal year ended June 30, 2018, as well as the financial statements and the other information incorporated by reference herein, before making an investment decision.

Our Company

We are a leading developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. Our lead indications are critical limb ischemia, or CLI, recovery following surgery for hip fracture, and acute radiation syndrome, or ARS.  Each of these indications is a severe unmet medical need.

PLX cells are derived from a class of placental cells that are harvested from donated placenta at the time of full term healthy delivery of a baby. PLX cell products require no tissue matching prior to administration. They are produced using our proprietary three-dimensional expansion technology. Our manufacturing facility complies with the European, Japanese, Israeli and U.S. Food and Drug Administration’s current Good Manufacturing Practice requirements and has been approved by the European and Israeli regulators for production of PLX-PAD for late stage trials and marketing. If we obtain FDA and other regulatory approvals to market PLX cells, we expect to have in-house production capacity to grow clinical-grade PLX cells in commercial quantities.

Our goal is to make significant progress with our robust clinical pipeline and our anticipated pivotal trials in order to ultimately bring innovative, potent therapies to patients who need new treatment options. We expect to demonstrate a real-world impact and value from our pipeline, technology platform and commercial-scale manufacturing capacity. Our business model for commercialization and revenue generation includes, but is not limited to, direct sale of our products, partnerships, licensing deals, and joint ventures with pharmaceutical companies.

We aim to shorten the time to commercialization of our product candidates by leveraging unique accelerated regulatory pathways that exist in the United States, Europe and Japan to bring innovative products that address life-threatening diseases to the market efficiently.  We believe that these accelerated pathways create substantial opportunities for us and for the cell therapy industry as a whole.

Corporate Information

We were incorporated as a Nevada corporation in 2001. We have a wholly owned subsidiary in Israel called Pluristem Ltd.  Our executive offices are located at MATAM Advanced Technology Park, Building No. 5, Haifa, Israel, our telephone number is 011 972 74 710 8759 and our website address is www.pluristem.com. This reference to our website is an inactive textual reference only, and is not a hyperlink. The information on our website is not incorporated by reference in this prospectus supplement and should not be considered to be part of this prospectus supplement. You should not consider the contents of our website in making an investment decision with respect to the securities.
 
S - 1
 
THE OFFERING
 
Common stock to be offered by us
 
 
Shares having an aggregate offering price of up to $50,000,000.
 
Common stock to be outstanding after this offering
  
Up to 159,912,892 shares, assuming sales at a price of $1.16 per share, which was the closing price of our common stock on The Nasdaq Capital Market on February 1, 2019. The actual number of shares issued will vary depending on the sales price under this offering.
 
Plan of Distribution
 
“At the market offering” of shares of common stock. The sale of shares of our common stock under this prospectus supplement, if any, may be made by any method permitted by law deemed to be and an “at the market offering” as defined in Rule 415(a)(4) of the Securities Act. See “Plan of Distribution” on page S-6 of this prospectus supplement. 
     
Use of Proceeds
 
We expect to use the net proceeds of this offering, if any, for research and product development activities, clinical trial activities, investment in capital equipment and for working capital and other general corporate purposes. See “Use of Proceeds” on page S-4.
 
Risk Factors
 
See “Risk Factors” beginning on page S-3 of this prospectus supplement and page 2 of the accompanying prospectus and under similar headings in other documents filed after the date hereof and incorporated by reference into this prospectus supplement and the accompanying prospectus for a discussion of the risks you should carefully consider before deciding to invest in our securities.
 
Listing on Nasdaq Capital Market and TASE
 
Our common stock is listed on The Nasdaq Capital Market under the symbol “PSTI” and on the TASE under the symbol “PLTR.”

The number of shares of common stock that will be outstanding after this offering as shown above is based on 116,809,444 shares of common stock outstanding as of December 31, 2018 and assumes no exercise of outstanding options or warrants to purchase additional shares and excludes as of such date:
 
 
·
985,800 shares of common stock issuable upon the exercise of outstanding stock options as of December 31, 2018 at a weighted-average exercise price of $0.00001 per share;
 
 
·
3,833,998  shares of common stock reserved for future issuances under our stock option plans;
 
 
·
11,700,278 shares of common stock issuable upon the exercise of outstanding warrants as of December 31, 2018 at a weighted-average exercise price of $1.91 per share; and
 
 
·
9,922,569 shares of common stock issuable upon the vesting of outstanding restricted stock and restricted stock units as of December 31, 2018.

Unless otherwise indicated, all information in this prospectus supplement assumes no exercise of the outstanding options or warrants described above.
 

S - 2
RISK FACTORS

An investment in our common stock involves significant risks. You should carefully consider the risk factors contained in in our filings with the SEC, including our Annual Report on Form 10-K for the fiscal year ended June 30, 2018, as well as all of the information contained in this prospectus supplement, the accompanying prospectus and the documents incorporated by reference herein or therein, as well as any amendment or update to our risk factors reflected in subsequent filings with the SEC, before you decide to invest in our common stock. Our business, prospects, financial condition and results of operations may be materially and adversely affected as a result of any of such risks. The value of our common stock could decline as a result of any of these risks. You could lose all or part of your investment in our common stock. Some of our statements in sections entitled “Risk Factors” are forward-looking statements. The risks and uncertainties we have described are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our business, prospects, financial condition and results of operations.

Risks Related to this Offering
 
Sales of our common stock in this offering, or the perception that such sales may occur, could cause a drop in the market price of our common stock.
 
We may issue and sell shares of our common stock for aggregate gross proceeds of up to $50 million from time to time in connection with this offering. The issuance and sale from time to time of these new shares of common stock, or our ability to issue these new shares of common stock in this offering could have the effect of depressing the market price of our common stock.
 
Our management will have broad discretion over the use of the net proceeds from this offering, you may not agree with how we use the proceeds, and the proceeds may not be invested successfully.
 
Our management will have broad discretion as to the use of the net proceeds from any offering by us and could use them for purposes other than those contemplated at the time of this offering. Accordingly, you will be relying on the judgment of our management with regard to the use of these net proceeds, and you will not have the opportunity, as part of your investment decision, to assess whether the proceeds are being used appropriately. It is possible that the proceeds will be invested in a way that does not yield a favorable, or any, return for us.
 
You may experience immediate and substantial dilution in the book value per share of the common stock you purchase in the offering.
 
The offering price per share in this offering may exceed the pro forma net tangible book value per share of our common stock outstanding prior to this offering. Assuming that an aggregate of 43,103,448 shares of our common stock are sold at a price of $1.16 per share, the last reported sale price of our common stock on The Nasdaq Capital Market on February 1, 2019, for aggregate gross proceeds of up to approximately $50 million, and after deducting commissions and estimated aggregate offering expenses payable by us, you will experience immediate dilution of $0.76 per share, representing the difference between our pro forma as adjusted net tangible book value per share as of December 31, 2018 after giving effect to this offering and the assumed offering price. The exercise of outstanding stock options and warrants will result in further dilution of your investment. See the section below entitled “Dilution” for a more detailed illustration of the dilution you would incur if you participate in this offering.
 
We may sell additional shares of our common stock to fund our operations, which sales may occur during or immediately after sales pursuant to this offering are commenced, which would result in dilution to our shareholders.
 
In order to raise additional funds to support our operations, we may sell additional shares of our common stock, which would result in dilution to all of our shareholders that may adversely impact our business. See “Dilution.” In particular, at any time, including during the pendency of this offering, we may sell additional shares of our common stock, other than pursuant to this offering, in amounts that may be material to us, which may be in amounts that are equal to or greater than the size of this offering, including, without limitation, through underwritten public offerings, privately negotiated transactions, block trades, or any combination of the above, subject, in certain circumstances, to the consent of the Agent.  We cannot assure you that we will be able to sell shares or other securities in any other offering at a price per share that is equal to or greater than the price per share paid by investors in this offering, and investors purchasing shares or other securities in the future could have rights superior to existing shareholders. The price per share at which we sell additional shares of our common stock or other securities convertible into or exchangeable for our common stock in future transactions may be higher or lower than the price per share in this offering.

S - 3
 
USE OF PROCEEDS
 
We intend to use the net proceeds from this offering, if any, for research and product development activities, clinical trial activities, investment in capital equipment and for working capital and other general corporate purposes. Pending the application of the net proceeds, we intend to invest the net proceeds in bank deposits or investment-grade, interest-bearing securities subject to any investment policies our investment committee may determine from time to time. We have not yet determined the amount of net proceeds to be used specifically for any of the foregoing purposes. Accordingly, our management will have significant discretion and flexibility in applying the net proceeds from this offering.

DIVIDEND POLICY
 
We have never declared or paid any cash dividends on our common stock.  We intend to retain any future earnings to finance the growth and development of our business and do not anticipate paying any cash dividends in the foreseeable future.  Any dividends paid will be solely at the discretion of our board of directors.

S - 4
 
DILUTION
 
If you purchase shares of our common stock in this offering, your interest will be diluted to the extent of the difference between the public offering price per share and the net tangible book value per share of our common stock after this offering. Our net tangible book value as of December 31, 2018, was approximately $15.2 million, or approximately $0.13 per share. Net tangible book value per share is equal to total tangible assets minus the sum of total tangible liabilities divided by the total number of shares outstanding.  
 
After giving effect to the sale of our common stock during the term of the sales agreement with Jefferies in the aggregate amount of $50,000,000 at an assumed offering price of $1.16 per share, the last reported sale price of our common stock on The Nasdaq Capital Market on February 1, 2019, and after deducting commissions and estimated aggregate offering expenses payable by us, our net tangible book value as of December 31, 2018 would have been $63.6 million, or $0.40 per share of our common stock. This amount represents an immediate increase in net tangible book value to existing shareholders of $0.27 per share and an immediate dilution in net tangible book value of $0.76 per share to purchasers of our shares of common stock in this offering, as illustrated in the following table:
 
Assumed public offering price per share
        
$
1.16
  
    Net tangible book value per share as of December 31, 2018
  
$
0.13
          
    Increase in net tangible book value per share after giving effect to this offering
  
$
0.27
          
 
                
Pro forma net tangible book value per share as of December 31, 2018
          
$
0.40
  
 
                
Dilution in net tangible book value per share to new investors
          
$
0.76
  
 
The table above assumes for illustrative purposes that an aggregate of 43,103,448  shares of our common stock are sold during the term of the sales agreement with Jefferies at a price of $1.16 per share, the last reported sale price of our common stock on The Nasdaq Capital Market on February 1, 2019, for aggregate gross proceeds of $50,000,000. In fact, the shares subject to the sales agreement with Jefferies will be sold, if at all, from time to time at prices that may vary. An increase of $1.00 per share in the price at which the shares are sold from the assumed offering price of $1.16 per share shown in the table above, assuming all of our common stock in the aggregate amount of $50,000,000 during the term of the sales agreement with Jefferies is sold at that price, would increase our adjusted net tangible book value per share after the offering to $0.45 per share and would increase the dilution in net tangible book value per share to new investors in this offering to $1.71 per share, after deducting commissions and estimated aggregate offering expenses payable by us. A decrease of $1.00 per share in the price at which the shares are sold from the assumed offering price of $1.16 per share shown in the table above, assuming all of our common stock in the aggregate amount of $50,000,000 during the term of the sales agreement with Jefferies is sold at that price, would decrease our adjusted net tangible book value per share after the offering to $0.15 per share and would decrease the dilution in net tangible book value per share to new investors in this offering to $0.01 per share, after deducting commissions and estimated aggregate offering expenses payable by us. This information is supplied for illustrative purposes only.

The discussion and table above are based on 116,809,444 shares outstanding as of December 31, 2018 and exclude as of that date:

·
985,800 shares of common stock issuable upon the exercise of outstanding stock options as of December 31, 2018 at a weighted-average exercise price of  $0.00001 per share;
 
·
3,833,998 shares of common stock reserved for future issuances under our stock option plans;
 
·
11,700,278 shares of common stock issuable upon the exercise of outstanding warrants as of December 31, 2018 at a weighted-average exercise price of $1.91 per share; and
 
·
9,922,569 shares of common stock issuable upon the vesting of outstanding restricted stock and restricted stock units as of December 31, 2018.
 
The table above assumes no exercise of outstanding options or warrants prior to this offering or issued but unvested restricted stock units. To the extent that options or warrants are exercised, there will be further dilution to new investors.

To the extent that outstanding options or warrants outstanding as of December 31, 2018 have been or may be exercised or unvested restricted stock units have been or may be issued, investors purchasing our common stock in this offering may experience further dilution. In addition, we may choose to raise additional capital due to market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the issuance of these securities could result in further dilution to our stockholders. 
 
S - 5

PLAN OF DISTRIBUTION

We have entered into an Open Market Sales AgreementSM, or sales agreement, with Jefferies under which we may issue and sell shares of our common stock from time to time for an aggregate sales price of up to $50.0 million through Jefferies. The sales agreement is filed with the SEC as an exhibit to a Current Report on Form 8-K and incorporated by reference into the registration statement of which this prospectus supplement is a part. Sales of our common stock, if any, under this prospectus supplement will be made by any method that it deemed to be an “at the market offering” as defined in Rule 415(a)(4) promulgated under the Securities Act, including sales made directly on or through The Nasdaq Capital Market or any existing trading market for our common stock.
 
When requested by us, Jefferies will offer shares of common stock subject to the terms and conditions of the sales agreement, which may be on a daily basis for periods of time, or as we may otherwise agree with Jefferies. We will designate the maximum amount shares of common stock to be sold through Jefferies when we request Jefferies to do so. Jefferies has agreed, subject to the terms and conditions of the sales agreement, to use its commercially reasonable efforts to execute our orders to sell, as our sales agent and on our behalf, of shares of our common stock submitted to Jefferies from time to time by us, consistent with its normal sales and trading practices. We may instruct Jefferies not to place shares of common stock at or below a price designated by us. In any event, shares of common stock shall be placed by Jefferies substantially at market price. We or Jefferies may suspend the offering of shares of common stock under the sales agreement upon proper notice to the other party.
 
If we and Jefferies so agree, Jefferies may act as principal in connection with the placement of the securities offered hereby.
 
We will pay Jefferies a commission of 3.0% of the gross proceeds of any shares sold through it pursuant to this prospectus supplement, and reimburse Jefferies for up to $50,000 of its expenses, including fees and disbursements to its legal counsel. The estimated offering expenses payable by us, in addition to such commission and expenses, are approximately $30,000, which includes legal, accounting and printing costs and various other fees associated with registering the shares of common stock. The remaining sale proceeds, after deducting any other transaction fees, will equal our net proceeds from the sale of such shares.
 
Jefferies will provide written confirmation to us before the open on The Nasdaq Capital Market on the day following each day on which shares of common stock are sold under the sales agreement. Each confirmation will include the number of shares sold on that day, the aggregate gross proceeds of such sales and the net proceeds to the Company. Settlement for sales of common stock will occur, unless otherwise agreed, on the second business day following the date on which such sales were made.  There is no arrangement for funds to be received in an escrow, trust or similar arrangement.
 
In connection with the sale of our common stock on our behalf, Jefferies will be deemed to be an “underwriter” within the meaning of the Securities Act and the compensation of Jefferies will be deemed to be underwriting commissions or discounts. We have agreed to indemnify Jefferies against certain liabilities, including liabilities under the Securities Act. We have also agreed to contribute to payments Jefferies may be required to make in respect of such liabilities.
 
S - 6
The offering of shares of common stock pursuant to the sales agreement will terminate upon the earlier of (i) the sale of all shares of common stock subject to the sales agreement and (ii) the termination of the sales agreement according to its terms by either Jefferies or us.
 
Jefferies and its affiliates may in the future provide various investment banking, commercial banking, financial advisory and other services to us and our affiliates and may in the future receive customary fees. In the course of its business, Jefferies may actively trade our securities for its own account or for the accounts of customers, and, accordingly, Jefferies may at any time hold long or short positions in such securities. To the extent required by Regulation M, Jefferies will not engage in any market making activities involving our common stock while the offering is ongoing under this prospectus supplement.
 
LEGAL MATTERS
 
The validity of the securities offered hereby will be passed upon for us by Zysman, Aharoni, Gayer and Sullivan & Worcester LLP, New York, New York. Jefferies LLC is being represented in connection with this offering by Cooley LLP, New York, New York.

EXPERTS
 
 The consolidated financial statements of Pluristem Therapeutics Inc. appearing in our Annual Report on Form 10-K for the fiscal year ended June 30, 2018 and the effectiveness of the internal control over financial reporting of Pluristem Therapeutics Inc. as of June 30, 2018, have been audited by Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, independent registered public accounting firm, as set forth in their reports thereon (which contains an explanatory paragraph describing conditions that raise substantial doubt about the Company’s ability to continue as a going concern as described in Note 1(b) to the consolidated financial statements), included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference in reliance upon such reports given on the authority of such firm as experts in accounting and auditing.
 
WHERE YOU CAN FIND MORE INFORMATION
 
We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public over the Internet at the SEC’s website at www.sec.gov. Copies of certain information filed by us with the SEC are also available on our website at www.pluristem.com. Our website is not a part of this prospectus supplement and is not incorporated by reference in this prospectus supplement. These reference to websites are inactive textual references only, and are not hyperlinks.
 
This prospectus supplement is part of a registration statement we filed with the SEC. This prospectus supplement and the accompanying prospectus omit some information contained in the registration statement in accordance with SEC rules and regulations. You should review the information and exhibits in the registration statement for further information on us and our consolidated subsidiary and the securities we are offering. Statements in this prospectus supplement and the accompanying prospectus concerning any document we filed as an exhibit to the registration statement or that we otherwise filed with the SEC are not intended to be comprehensive and are qualified by reference to these filings. You should review the complete document to evaluate these statements. You can obtain a copy of the registration statement from the SEC’s website.
 
S - 7
INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE
 
We are “incorporating by reference” certain documents we file with the SEC, which means that we can disclose important information to you by referring you to those documents. The information in the documents incorporated by reference is considered to be part of this prospectus supplement. Statements contained in documents that we file with the SEC and that are incorporated by reference in this prospectus supplement will automatically update and supersede information contained in this prospectus, including information in previously filed documents or reports that have been incorporated by reference in this prospectus supplement, to the extent the new information differs from or is inconsistent with the old information.
 
We have filed or may file the following documents with the SEC. These documents are incorporated herein by reference as of their respective dates of filing:

(a)          Our Annual Report on Form 10-K for the year ended June 30, 2018, as filed with the SEC on September 12, 2018;

(b)          Our Quarterly Reports on Form 10-Q for the quarters ended September 30, 2018 and December 31, 2018, as filed with the SEC on November 7, 2018 and February 6, 2019, respectively; and

(c)           The description of our common stock contained in the Registration Statement on Form 8-A filed on December 10, 2007, under the Exchange Act, including any amendment or report filed or to be filed for the purpose of updating such description.
 
All documents filed by us pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act until all of the securities to which this prospectus supplement relates has been sold or the offering is otherwise terminated, except in each case for information contained in any such filing where we indicate that such information is being furnished and is not to be considered “filed” under the Exchange Act, will be deemed to be incorporated by reference in this prospectus supplement and the accompanying prospectus and to be a part hereof from the date of filing of such documents.
 
We will provide a copy of the documents we incorporate by reference, at no cost, to any person who receives this prospectus supplement. To request a copy of any or all of these documents, you should write or telephone 011-972-74-7108607 us at MATAM Advanced Technology Park, Building No. 5, Haifa, 3508409, Israel, Attention: Erez Egozi.
 
S - 8
 
 

$200,000,000
Common Stock
Preferred Stock
Warrants
Units
 
We may from time to time sell common stock, preferred stock and warrants to purchase common stock, and units of two or more of such securities, in one or more offerings for an aggregate initial offering price of $200,000,000. We refer to the common stock, the preferred stock, the warrants to purchase common stock and the units collectively as the securities. This prospectus describes the general manner in which our securities may be offered using this prospectus. Other than in connection with the exercise of certain outstanding warrants, we will specify in an accompanying prospectus supplement the terms of the securities to be offered and sold. We may sell these securities to or through underwriters or dealers, directly to purchasers or through agents. We will set forth the names of any underwriters, dealers or agents in an accompanying prospectus supplement. You should carefully read this prospectus and any accompanying supplements before you decide to invest in any of these securities.
 
Our common stock is traded on the NASDAQ Capital Market, or Nasdaq, under the symbol “PSTI” and on the Tel Aviv Stock Exchange under the symbol “PLTR.”
 
Investing in our securities involves risks. See “Risk Factors” on page 2 of this prospectus.
 
Neither the Securities and Exchange Commission, or the SEC, nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.
 
The date of this prospectus is June 30, 2017.
 
 
TABLE OF CONTENTS
 
1
1
2
2
3
3
3
4
6
7
10
10
10
11
 
You should rely only on the information contained in this prospectus, any prospectus supplement and the documents incorporated by reference herein or therein, or to which we have referred you. We have not authorized anyone to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. This prospectus and any prospectus supplement do not constitute an offer to sell, or a solicitation of an offer to purchase, the securities offered by this prospectus and any prospectus supplement in any jurisdiction to or from any person to whom or from whom it is unlawful to make such offer or solicitation of an offer in such jurisdiction. You should not assume that the information contained in this prospectus, any prospectus supplement or any document incorporated by reference is accurate as of any date other than the date indicated in the applicable document.
 
Neither the delivery of this prospectus nor any distribution of securities pursuant to this prospectus shall, under any circumstances, create any implication that there has been no change in the information set forth or incorporated by reference into this prospectus or in our affairs since the date of this prospectus. Our business, financial condition, results of operations and prospects may have changed since that date.
 
Our name and logo and the names of our products are our trademarks or registered trademarks. Unless the context otherwise requires, references in this prospectus to “Pluristem,” “we,” “us,” and “our” refer to Pluristem Therapeutics Inc. and its subsidiary as required by the context.

ABOUT THIS PROSPECTUS
 
This prospectus is part of a registration statement that we filed with the SEC using a “shelf” registration process. Under this shelf registration process, we may, from time to time, sell any combination of the securities described in this prospectus in one or more offerings up to a total dollar amount of $200,000,000. This prospectus describes the securities we may offer and the general manner in which our securities may be offered by this prospectus. Each time we sell securities (other than in connection with the exercise of certain outstanding warrants), we will provide a prospectus supplement that will contain specific information about the terms of that offering. We may also add, update or change in the prospectus supplement any of the information contained in this prospectus. To the extent there is a conflict between the information contained in this prospectus and the prospectus supplement, you should rely on the information in the prospectus supplement, provided that if any statement in one of these documents is inconsistent with a statement in another document having a later date - for example, a document incorporated by reference in this prospectus or any prospectus supplement - the statement in the document having the later date modifies or supersedes the earlier statement.

OUR COMPANY
 
This summary highlights information contained in the documents incorporated herein by reference. Before making an investment decision, you should read the entire prospectus, and our other filings with the SEC, including those filings incorporated herein by reference, carefully, including the sections entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements.”
 
We are a leading developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. Our lead indications are critical limb ischemia, or CLI, recovery after surgery for femoral neck fracture, and acute radiation syndrome, or ARS. Pivotal, multinational clinical trials are planned for our PLX-PAD product candidate in CLI and femoral neck fracture, and for our PLX-R18 product candidate in the hematologic component of ARS. Each of these indications is a severe unmet medical need. 

PLX cells are derived from a class of placental cells that are harvested from donated placentas at the time of full term delivery of a live baby. PLX cell products require no tissue matching prior to administration. They are produced using our proprietary three-dimensional expansion technology. Our manufacturing facility complies with the U.S. Food and Drug Administration’s, or FDA’s current Good Manufacturing Practice requirements and has been approved by the European, Japanese and Israeli regulatory authorities for production of PLX-PAD for late stage trials and marketing. We expect to have in-house production capacity to grow clinical-grade PLX cells in commercial quantities.
 
Our goal is to make significant progress with our robust clinical pipeline and our anticipated pivotal trials in order to ultimately bring innovative, potent therapies to patients who need new treatment options. We intend to shorten the time to commercialization of our first product candidate, PLX-PAD, by leveraging the unique accelerated regulatory pathways that exist in Europe and Japan to bring innovative products that address life-threatening diseases to the market efficiently. We believe that these accelerated pathways create substantial opportunities for us and for the cell therapy industry as a whole. We are pursuing these accelerated pathways for PLX-PAD in CLI and femoral neck fracture. Our second product candidate, PLX R18, is under development in the United States for ARS via the Animal Rule regulatory pathway, which may result in approval without the prior performance of human efficacy trials. We expect to demonstrate a real-world impact and value from our pipeline, technology platform and commercial-scale manufacturing capacity.

We were incorporated as a Nevada corporation in 2001. We have a wholly owned subsidiary in Israel called Pluristem Ltd.  Our executive offices are located at MATAM Advanced Technology Park, Building No. 5, Haifa, Israel, our telephone number is 011 972 74 710 8759 and our website address is www.pluristem.com. This reference to our website is an inactive textual reference only, and is not a hyperlink. The information on our website is not incorporated by reference in this prospectus and should not be considered to be part of this prospectus. You should not consider the contents of our website in making an investment decision with respect to the securities.
 
1
RISK FACTORS
 
An investment in our securities involves significant risks. You should carefully consider the risk factors below as well as risk factors contained in any prospectus supplement and in our filings with the SEC, including our Annual Report on Form 10-K for the fiscal year ended June 30, 2016 as well as all of the information contained in this prospectus, any prospectus supplement and the other documents incorporated by reference herein or therein, before you decide to invest in our securities. Our business, prospects, financial condition and results of operations may be materially and adversely affected as a result of any of such risks.  The value of our securities could decline as a result of any of these risks.  You could lose all or part of your investment in our securities.  The risks and uncertainties we have described are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our business, prospects, financial condition and results of operations.

Although we have entered into a term sheet with Innovative Medical Management Co. Ltd., there can be no assurance that a definitive agreement will be signed or that such proposed investment will be made.
 
We have signed a binding term sheet with Innovative Medical Management Co. Ltd., or Innovative Medical, related to Innovative Medical’s proposed investment of approximately $30,000,000. Although the term sheet provided that definitive agreements would be executed by December 26, 2016, we announced on December 23, 2016, that, due to a recently adopted Chinese policy relating to outbound investments by Chinese companies, we agreed to extend the time of execution of the definitive agreements relating to Innovative Medical’s proposed investment. As a result of this recently adopted Chinese policy, we now plan to continue the discussions with respect to the definitive agreements until we have received further clarification about such policies, which we initially expected to receive during the first half of 2017. We now do not expect the needed clarifications regarding the agreement with Innovative Medical to be provided by the end of the first half of 2017. Thus, it is possible that the definitive agreements will not be executed, or that they may be executed on terms and conditions that are materially different than those set forth in the term sheet. There can be no assurance that we will execute the definitive agreements or that Innovative Medical’s proposed investment will be made.
 
Although we have entered into a term sheet with Sosei Corporate Venture Capital Ltd. there can be no assurance that a definitive agreement will be signed or that such proposed joint venture will be formed.
 
We have signed a binding term sheet with Sosei Corporate Venture Capital Ltd., or Sosei CVC, for the establishment of for the establishment of a new Japanese corporation, or NewCo, for the clinical development and commercialization of our PLX-PAD cell therapy product in Japan. While the parties have executed a term sheet and we believe such definitive agreements will be finalized in the coming months, there is no guarantee that we will be successful in executing agreements by then. It is possible that the definitive agreements will not be executed, or that they may be executed on terms and conditions that are materially different than those set forth in the term sheet. There can be no assurance that we will execute the definitive agreements or that the proposed joint venture with Sosei CVC will be completed.
 
CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION
 
The statements contained in this prospectus, any prospectus supplement and the documents we incorporate by reference herein or therein that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. Such forward-looking statements may be identified by, among other things, the use of forward-looking terminology such as “believes,” “intends,” “plans,” “expects,” “may,” “will,” “should,” or “anticipates” or the negative thereof or other variations thereon or comparable terminology, and similar expressions are intended to identify forward-looking statements.  We remind readers that forward-looking statements are merely predictions and therefore inherently subject to uncertainties and other factors and involve known and unknown risks that could cause the actual results, performance, levels of activity, or our achievements, or industry results, to be materially different from any future results, performance, levels of activity, achievements or industry results, expressed or implied by such forward-looking statements. The factors discussed herein, including those risks described under the heading “Risk Factors” herein and in the documents we incorporate by reference, as well as those discussed elsewhere in this prospectus and any prospectus supplement could cause actual results and developments to be materially different from those expressed in or implied by such statements. In addition, historic results of scientific research, clinical and preclinical trials do not guarantee that the conclusions of future research or trials would not suggest different conclusions. Also, historic results referred to this prospectus, any prospectus supplement and the documents we incorporate by reference may be interpreted differently in light of additional research, clinical and preclinical trials results. Except as required by law we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.
 
2
USE OF PROCEEDS
 
Unless we otherwise indicate in an applicable prospectus supplement, we currently intend to use the net proceeds from the sale of the securities for research and product development activities, clinical trial activities, investment in capital equipment and for working capital and other general corporate purposes.
 
We may set forth additional information on the use of net proceeds from the sale of securities we offer under this prospectus in a prospectus supplement relating to the specific offering. Pending the application of the net proceeds, we intend to invest any proceeds in a variety of capital preservation instruments such as bank deposits or investment-grade, interest-bearing securities subject to any investment policies our investment committee may determine from time to time.
 
THE SECURITIES WE MAY OFFER
 
The descriptions of the securities contained in this prospectus, together with any applicable prospectus supplement, summarize the material terms and provisions of the various types of securities that we may offer. We will describe in any applicable prospectus supplement relating to any securities the particular terms of the securities offered by that prospectus supplement. If we so indicate in any applicable prospectus supplement, the terms of the securities may differ from the terms we have summarized below. We may also include in any prospectus supplement information, where applicable, about material U.S. federal income tax consequences relating to the securities, and the securities exchange or market, if any, on which the securities will be listed.
 
We may sell from time to time, in one or more offerings, one or more of the following securities:
 
·
common stock;
 
·
preferred stock;
 
·
warrants to purchase common stock; and
 
·
units of two or more of the securities mentioned above.
 
The total initial offering price of all securities that we may issue in these offerings will not exceed $200,000,000.
 
DESCRIPTION OF CAPITAL STOCK
 
The following summary is a description of the material terms of our share capital. We encourage you to read our Certificate of Incorporation, as amended, and Amended and Restated By-laws which have been filed with the SEC, as well as the applicable provisions of the Nevada Revised Statutes.
 
Our authorized capital stock currently consists of 200,000,000  shares of common stock, of which there were 96,171,868 shares outstanding as of March 31, 2017, and 10,000,000 shares of “blank check” preferred stock, none of which are outstanding. The following statements set forth the material terms of our capital stock; however, reference is made to the more detailed provisions of, and these statements are qualified in their entirety by reference to, our Articles of Incorporation and Bylaws, copies of which are referenced as exhibits herein, and the provisions of Nevada General Corporation Law.  Except for our ability to issue additional securities, including preferred stock with terms that may be determined at a later date by our Board, there are no provisions in our Articles of Incorporation or Bylaws that would delay, defer or prevent a change in our control.
 
3
Common Stock
 
Except as otherwise required by applicable law and subject to the preferential rights of any outstanding preferred stock, all voting rights are vested in and exercised by the holders of common stock with each share of our common stock being entitled to one vote.  In the event of liquidation, holders of the common stock are entitled to share ratably in the distribution of assets remaining after payment of liabilities, if any.  Holders of the common stock have no cumulative voting rights and no preemptive or other rights to subscribe for shares. Holders of common stock are entitled to such dividends as may be declared by the Board of Directors out of funds legally available therefor.
 
Blank Check Preferred Stock
 
Our Board of Directors is empowered, without further action by stockholders, to issue from time to time one or more series of preferred stock, with such designations, rights, preferences and limitations as the Board may determine by resolution. The rights, preferences and limitations of separate series of preferred stock may differ with respect to such matters among such series as may be determined by the Board, including, without limitation, the rate of dividends, method and nature of payment of dividends, terms of redemption, amounts payable on liquidation, sinking fund provisions (if any), conversion rights (if any) and voting rights. Certain issuances of preferred stock may have the effect of delaying or preventing a change in control of our company that some stockholders may believe is not in their interest.
 
Transfer Agent
 
American Stock Transfer and Trust Company, LLC is the registrar and transfer agent for our common shares.  Their address is 6201 15th Avenue, 2nd Floor, Brooklyn, NY 11219, telephone: (718) 921-8261, (800) 937-5449.
 
Nevada Anti-Takeover Law
 
Nevada revised statutes sections 78.378 to 78.3793 provide state regulation over the acquisition of a controlling interest in certain Nevada corporations unless the articles of incorporation or bylaws of the corporation provide that the provisions of these sections do not apply.  This statute currently does not apply to our Company because in order to be applicable we would have to have as shareholders a specified number of Nevada residents and we would have to do business in Nevada directly or through an affiliate.
 
DESCRIPTION OF WARRANTS
 
The following description, together with the additional information we may include in any applicable prospectus supplement, summarizes the material terms and provisions of the warrants that we may offer under this prospectus and the related warrant agreements and warrant certificates. While the terms summarized below will apply generally to any warrants that we may offer, we will describe the particular terms of any series of warrants (and any securities issuable upon exercise of such warrants) in more detail in the applicable prospectus supplement. If we so indicate in a prospectus supplement, the terms of any warrants offered under that prospectus supplement may differ from the terms we describe below. Specific warrant agreements will contain additional important terms and provisions and will be incorporated by reference as an exhibit to the registration statement.
 
4
General
 
We may issue warrants for the purchase of common stock in one or more series. We may issue warrants independently or together with common stock, and the warrants may be attached to or separate from the common stock.
 
We will evidence each series of warrants by warrant certificates that we will issue under a separate agreement or by warrant agreements that we will enter into directly with the purchasers of the warrants. If we evidence warrants by warrant certificates, we will enter into a warrant agreement with a warrant agent. We will indicate the name and address of the warrant agent, if any, in the applicable prospectus supplement relating to a particular series of warrants.
 
We will describe in the applicable prospectus supplement the terms of the series of warrants, including:
 
·
the offering price and aggregate number of warrants offered;
 
·
the currency for which the warrants may be purchased or exercised;
 
·
if applicable, the terms of the common stock with which the warrants are issued and the number of warrants issued with such common stock;
 
·
if applicable, the date on and after which the warrants and the related common stock will be separately transferable;
 
·
the number of shares of common stock or other securities purchasable upon the exercise of one warrant and the price at which these shares may be purchased upon such exercise;
 
·
the manner in which the warrants may be exercised, which may include by cashless exercise;
 
·
the effect of any merger, consolidation, sale or other disposition of our business on the warrant agreement and the warrants;
 
·
the terms of any rights to redeem or call the warrants;
 
·
any provisions for changes to or adjustments in the exercise price or number of shares of common stock issuable upon exercise of the warrants;
 
·
the dates on which the right to exercise the warrants will commence and expire;
 
·
the manner in which the warrant agreement and warrants may be modified;
 
·
the material United States federal income tax consequences of holding or exercising the warrants;
 
·
the terms of the common stock issuable upon exercise of the warrants; and
 
·
any other specific terms, preferences, rights or limitations of or restrictions on the warrants.
 
Before exercising their warrants, holders of warrants will not have any of the rights of holders of the common stock purchasable upon such exercise, including the right to receive dividends, if any, or payments upon our liquidation, dissolution or winding up or to exercise voting rights, if any.
 
5
Exercise of Warrants
 
Each warrant will entitle the holder to purchase the number of shares of common stock that we specify in the applicable prospectus supplement at the exercise price that we describe in the applicable prospectus supplement. Unless we otherwise specify in the applicable prospectus supplement, holders of the warrants may exercise the warrants at any time up to 5:00 P.M., Eastern U.S. time, on the expiration date that we set forth in the applicable prospectus supplement. After the close of business on the expiration date, unexercised warrants will become void.
 
Holders of the warrants may exercise the warrants by delivering to the warrant agent or us the warrant certificate or warrant agreement representing the warrants to be exercised together with specified information, and by paying the required amount to the warrant agent or us in immediately available funds, as provided in the applicable prospectus supplement. We will set forth on the reverse side of the warrant certificate or in the warrant agreement and in the applicable prospectus supplement the information that the holder of the warrant will be required to deliver to the warrant agent or us in connection with such exercise.
 
Upon receipt of the required payment and the warrant certificate or the warrant agreement, as applicable, properly completed and duly executed at the corporate trust office of the warrant agent, if any, at our offices or at any other office indicated in the applicable prospectus supplement, we will issue and deliver the common stock or other securities purchasable upon such exercise. If fewer than all of the warrants represented by the warrant certificate or warrant agreement are exercised, then we will issue a new warrant certificate or warrant agreement for the remaining amount of warrants.
 
Enforceability of Rights by Holders of Warrants
 
If we appoint a warrant agent, any warrant agent will act solely as our agent under the applicable warrant agreement and will not assume any obligation or relationship of agency or trust with any holder of any warrant. A single bank or trust company may act as warrant agent for more than one issue of warrants. A warrant agent will have no duty or responsibility in case of any default by us under the applicable warrant agreement or warrant, including any duty or responsibility to initiate any proceedings at law or otherwise, or to make any demand upon us. Any holder of a warrant may, without the consent of the related warrant agent or the holder of any other warrant, enforce by appropriate legal action its right to exercise, and receive the securities purchasable upon exercise of, its warrants.
 
Outstanding Warrants
 
The shares of common stock registered under the registration statement of which this prospectus is a part include 3,219,983 shares of common stock issuable upon exercise of warrants that were issued under our registration statement on Form S-3 declared effective on October 20, 2011 (Registration No. 333-177009).  Such warrants were issued on September 19, 2012, have an exercise price of $5.00 per share and expire on September 19, 2017. 
 
No prospectus supplement will be delivered in connection with the issuance of these shares of common stock pursuant to the exercise of such warrants.

DESCRIPTION OF UNITS
 
We may issue, in one or more series, units consisting of common stock, preferred stock and/or warrants for the purchase of common stock and/or preferred stock, in any combination.  While the terms we have summarized below will apply generally to any units that we may offer under this prospectus, we will describe the particular terms of any series of units in more detail in the applicable prospectus supplement.  The terms of any units offered under a prospectus supplement may differ from the terms described below.
 
We will file as exhibits to a prospectus supplement, or will incorporate by reference from reports that we file with the SEC, the form of unit agreement that describes the terms of the series of units we are offering, and any supplemental agreements, before the issuance of the related series of units.  The following summaries of material terms and provisions of the units are subject to, and qualified in their entirety by reference to, all the provisions of the unit agreement and any supplemental agreements applicable to a particular series of units.  We urge you to read the applicable prospectus supplement related to the particular series of units that we may offer under this prospectus and the complete unit agreement and any supplemental agreements that contain the terms of the units.
 
6
Each unit will be issued so that the holder of the unit is also the holder of each security included in the unit.  Thus, the holder of a unit will have the rights and obligations of a holder of each included security.  The unit agreement under which a unit is issued may provide that the securities included in the unit may not be held or transferred separately, at any time or at any time before a specified date.
 
We will describe in the applicable prospectus supplement the terms of the series of units, including:
 
·
the designation and terms of the units, including whether and under what circumstances the securities comprising the units may be held or transferred separately; and
 
·
any provisions for the issuance, payment, settlement, transfer or exchange of the units or the securities comprising the units.
 
The provisions described in this section, as well as those described under “Description of Capital Stock” and “Description of Warrants” will apply to each unit and to any common stock, preferred stock or warrant included in each unit, respectively.
 
We may issue units in such amounts and in such distinct series as we determine.

PLAN OF DISTRIBUTION
 
We may sell the securities being offered hereby in one or more of the following ways from time to time:
 
·
through agents to the public or to investors;
 
·
to one or more underwriters or distributors for resale to the public or to investors;
 
·
in “at the market offerings,” within the meaning of Rule 415(a)(4) of the Securities Act, to or through a market maker or into an existing trading market, on an exchange or otherwise;
 
·
directly to investors in privately negotiated transactions;
 
·
directly to a purchaser pursuant to what is known as an “equity line of credit” as described below;
 
·
through a combination of these methods of sale; or
 
·
upon exercise of outstanding warrants.
 
The securities that we distribute by any of these methods may be sold, in one or more transactions, at:
 
·
a fixed price or prices, which may be changed;
 
·
market prices prevailing at the time of sale;
 
·
prices related to prevailing market prices; or
 
·
negotiated prices.
 
7
The accompanying prospectus supplement will describe the terms of the offering of our securities, including:
 
·
the name or names of any agents or underwriters;
 
·
any securities exchange or market on which the common stock may be listed;
 
·
the purchase price and commission, if any, to be paid in connection with the sale of the securities being offered and the proceeds we will receive from the sale;
 
·
any over-allotment options pursuant to which underwriters may purchase additional securities from us;
 
·
any underwriting discounts or agency fees and other items constituting underwriters’ or agents’ compensation;
 
·
any public offering price; and
 
·
any discounts or concessions allowed or reallowed or paid to dealers.
 
If underwriters are used in the sale, they will acquire the securities for their own account and may resell the securities from time to time in one or more transactions, including negotiated transactions, at a fixed public offering price or at varying prices determined at the time of the sale. The obligations of the underwriters to purchase the securities will be subject to the conditions set forth in the applicable underwriting agreement. We may offer the securities to the public through underwriting syndicates represented by managing underwriters or by underwriters without a syndicate. Subject to certain conditions, the underwriters will be obligated to purchase all the securities offered by the prospectus supplement. We may change from time to time the public offering price and any discounts or concessions allowed or reallowed or paid to dealers.
 
If we use a dealer in the sale of the securities being offered pursuant to this prospectus or any prospectus supplement, we will sell the securities to the dealer, as principal. The dealer may then resell the securities to the public at varying prices to be determined by the dealer at the time of resale. The names of the dealers and the terms of the transaction will be specified in a prospectus supplement.
 
We may sell the securities directly or through agents we designate from time to time. We will name any agent involved in the offering and sale of securities and we will describe any commissions we will pay the agent in the prospectus supplement. Unless the prospectus supplement states otherwise, any agent will act on a best-efforts basis for the period of its appointment.
 
We may also sell securities pursuant to an “equity line of credit”. In such event, we will enter into a common stock purchase agreement with the purchaser to be named therein, which will be described in a Current Report on Form 8-K that we will file with the SEC. In that Form 8-K, we will describe the total amount of securities that we may require the purchaser to purchase under the purchase agreement and the other terms of purchase, and any rights that the purchaser is granted to purchase securities from us. In addition to our issuance of shares of common stock to the equity line purchaser pursuant to the purchase agreement, this prospectus (and the applicable prospectus supplement or post-effective amendment) also covers the resale of those shares from time to time by the equity line purchaser to the public. The equity line purchaser will be considered an “underwriter” within the meaning of Section 2(a)(11) of the Securities Act. Its resales may be effected through a number of methods, including without limitation, ordinary brokerage transactions and transactions in which the broker solicits purchasers and block trades in which the broker or dealer so engaged will attempt to sell the shares as agent, but may position and resell a portion of the block as principal to facilitate the transaction.  The equity line purchaser will be bound by various anti-manipulation rules of the SEC and may not, for example, engage in any stabilization activity in connection with its resales of our securities and may not bid for or purchase any of our securities or attempt to induce any person to purchase any of our securities other than as permitted under the Securities Exchange Act of 1934, as amended, or the Exchange Act.
 
8
We may sell our securities directly or through agents we designate from time to time. We will name any agent involved in the offering and sale of our common stock, and we will describe any commissions we will pay the agent in the prospectus supplement. Unless the prospectus supplement states otherwise, our agent will act on a best-efforts basis for the period of its appointment.
 
We may provide underwriters and agents with indemnification against civil liabilities related to offerings pursuant to this prospectus, including liabilities under the Securities Act, or contribution with respect to payments that the underwriters or agents may make with respect to these liabilities. Underwriters and agents may engage in transactions with, or perform services for, us in the ordinary course of business. We will describe such relationships in the prospectus supplement naming the underwriter or agent and the nature of any such relationship.
 
Rules of the SEC may limit the ability of any underwriters to bid for or purchase securities before the distribution of the shares of common stock is completed. However, underwriters may engage in the following activities in accordance with the rules:
 
·
Stabilizing transactions — Underwriters may make bids or purchases for the purpose of pegging, fixing or maintaining the price of the shares, so long as stabilizing bids do not exceed a specified maximum.
 
·
Options to purchase additional stock and syndicate covering transactions — Underwriters may sell more shares of our common stock than the number of shares that they have committed to purchase in any underwritten offering. This creates a short position for the underwriters. This short position may involve either “covered” short sales or “naked” short sales. Covered short sales are short sales made in an amount not greater than the underwriters’ option to purchase additional shares in any underwritten offering. The underwriters may close out any covered short position either by exercising their option or by purchasing shares in the open market. To determine how they will close the covered short position, the underwriters will consider, among other things, the price of shares available for purchase in the open market, as compared to the price at which they may purchase shares through their option. Naked short sales are short sales in excess of the option. The underwriters must close out any naked position by purchasing shares in the open market. A naked short position is more likely to be created if the underwriters are concerned that, in the open market after pricing, there may be downward pressure on the price of the shares that could adversely affect investors who purchase shares in the offering.
 
·
Penalty bids — If underwriters purchase shares in the open market in a stabilizing transaction or syndicate covering transaction, they may reclaim a selling concession from other underwriters and selling group members who sold those shares as part of the offering.

Similar to other purchase transactions, an underwriter’s purchases to cover the syndicate short sales or to stabilize the market price of our common stock may have the effect of raising or maintaining the market price of our common stock or preventing or mitigating a decline in the market price of our common stock. As a result, the price of the shares of our common stock may be higher than the price that might otherwise exist in the open market. The imposition of a penalty bid might also have an effect on the price of shares if it discourages resales of the shares.
 
If commenced, the underwriters may discontinue any of these activities at any time.
 
Our common stock is traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. One or more underwriters may make a market in our common stock, but the underwriters will not be obligated to do so and may discontinue market making at any time without notice. We cannot give any assurance as to liquidity of the trading market for our common stock.
 
Any underwriters who are qualified market makers on the NASDAQ Capital Market may engage in passive market making transactions in that market in the common stock in accordance with Rule 103 of Regulation M, during the business day prior to the pricing of the offering, before the commencement of offers or sales of the common stock. Passive market makers must comply with applicable volume and price limitations and must be identified as passive market makers. In general, a passive market maker must display its bid at a price not in excess of the highest independent bid for such security; if all independent bids are lowered below the passive market maker’s bid, however, the passive market maker’s bid must then be lowered when certain purchase limits are exceeded.
 
9
In compliance with guidelines of the Financial Industry Regulatory Authority, or FINRA, the maximum commission or discount to be received by any FINRA member or independent broker dealer may not exceed 8% of the aggregate amount of the securities offered pursuant to this prospectus and any applicable prospectus supplement.
 
Exercise of Outstanding Warrants
 
We will sell and deliver shares of our common stock directly to those holders who validly exercise certain warrants that were registered under a previous registration statement. No prospectus supplement will be delivered in connection with such transactions. See “Description of Warrants – Outstanding Warrants” on page 5 of this prospectus.
 
VALIDITY OF THE SECURITIES
 
Zysman, Aharoni, Gayer and Sullivan & Worcester LLP, New York, New York, passed upon the validity of the securities offered hereby.
 
EXPERTS
 
The consolidated financial statements of Pluristem Therapeutics Inc. appearing in our Annual Report on Form 10-K for the fiscal year ended June 30, 2016 and the effectiveness of the internal control over financial reporting of Pluristem Therapeutics Inc. as of June 30, 2016, have been audited by Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, independent registered public accounting firm, as set forth in their reports thereon, included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference in reliance upon such reports given on the authority of such firm as experts in accounting and auditing.

WHERE YOU CAN FIND MORE INFORMATION
 
We are subject to the reporting and information requirements of the Exchange Act and as a result file periodic reports and other information with the SEC. These periodic reports and other information will be available for inspection and copying at the SEC’s public reference room and the website of the SEC referred to below.
 
We have filed a registration statement on Form S-3 under the Securities Act with the SEC with respect to the shares of our common stock, warrants, preferred stock and units offered through this prospectus. This prospectus is filed as a part of that registration statement and does not contain all of the information contained in the registration statement and exhibits. We refer you to our registration statement and each exhibit attached to it for a more complete description of matters involving us, and the statements we have made in this prospectus are qualified in their entirety by reference to these additional materials.
 
You may read and copy the reports and other information we file with the SEC at the SEC’s Public Reference Room at 100 F Street, N.E., Washington D.C. 20549. You may also obtain copies of this information by mail from the public reference section of the SEC, 100 F Street, N.E., Washington, D.C. 20549, at prescribed rates. You may obtain information regarding the operation of the public reference room by calling the SEC at 1 (800) SEC-0330. The SEC also maintains a website that contains reports and other information about issuers, like us, who file electronically with the SEC. The address of that website is http://www.sec.gov. This reference to the SEC’s website is an inactive textual reference only, and is not a hyperlink.
 
10
INCORPORATION OF DOCUMENTS BY REFERENCE
 
We are “incorporating by reference” certain documents we file with the SEC, which means that we can disclose important information to you by referring you to those documents. The information in the documents incorporated by reference is considered to be part of this prospectus. Statements contained in documents that we file with the SEC and that are incorporated by reference in this prospectus will automatically update and supersede information contained in this prospectus, including information in previously filed documents or reports that have been incorporated by reference in this prospectus, to the extent the new information differs from or is inconsistent with the old information.
 
We have filed or may file the following documents with the SEC. These documents are incorporated herein by reference as of their respective dates of filing:

(a) Our Annual Report on Form 10-K for the year ended June 30, 2016 filed with the SEC on September 7, 2016;

                (b) Our Quarterly Reports on Form 10-Q for the quarters ended September 30, 2016, December 31, 2016 and March 31, 2017, as filed with the SEC on November 7, 2016, February 8, 2017 and May 8, 2017, respectively;
 
(c) Our Current Reports on Form 8-K filed with the SEC on October 25, 2016, November 10, 2016, December 20, 2016, December 23, 2016, January 11, 2017, January 17, 2017, January 20, 2017, March 29, 2017, March 30, 2017, May 3, 2017, May 25, 2017, June 20, 2017 and June 23, 2017; and

(d) The description of our common stock contained in the Registration Statement on Form 8-A filed on December 10, 2007, under the Exchange Act, including any amendment or report filed or to be filed for the purpose of updating such description.
 
All documents filed by us pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act until all of the securities to which this prospectus relates has been sold or the offering is otherwise terminated, except in each case for information contained in any such filing where we indicate that such information is being furnished and is not to be considered “filed” under the Exchange Act, will be deemed to be incorporated by reference in this prospectus and any accompanying prospectus supplement and to be a part hereof from the date of filing of such documents.
 
We will provide a copy of the documents we incorporate by reference, at no cost, to any person who receives this prospectus. To request a copy of any or all of these documents, you should write or telephone us at MATAM Advanced Technology Park, Building No. 5, Haifa, L3 31905, Israel, Attention: Erez Egozi.

11
 

 

Up to $50,000,000

Common Stock

 
PROSPECTUS SUPPLEMENT
 
 

Jefferies
 
February 6, 2019

 GRAPHIC 2 image0.jpg begin 644 image0.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#W^BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHS1F@ HHS1F@ HI,BC(H 6BDR*,BEM2YE*!8W4F^JS3@=ZA:Y7UK&5:Q2ILNF44PS@5GO=KZU M5EO!ZUF\38UC0N:YN1ZTQKP#O6$U][U7EU#WK)XLW6$N=";]1WI#J*^MM2\:4L =N=54=Q3#K*?W MA7"2ZH_K5-M4DSU-1]>L5_9YZ-_;*?WA2'6D_O"O.O[4DQU-1MJLGJ:C^T"O M[./2/[;3^\*/[;3^\*\S_M63U-']JR>IH_M ?]G'IG]MI_>%/&L(>XKS)=5D MSU-68]4?U--8^XGEQZ.-67^\*=_:B^M>?+JC^M3+J;>M5]>)_L\[T:DI[BI! M?J>]<*FIG^]5F/4S_>JEC"98&QVHO0>].%T#WKDX]2_VJLIJ /\ %6BQ9B\) M8Z<3@T_S!6#%? _Q5;6\7'WJUCB;F$J%C4\RE#UEB[7/6ITN >]5[W M4;JJ^JTEWCO6)+JH'\549=5!_BKFG6.N&' M-R;4,=ZH2ZIC^*L.74=W>J4EV3WKFE6;.B.&1OOJW^U4#:GGO7/-.3WJ,SGU MK&=4VC02-U]2]ZK/J)/>L=IB>],WFL'49T0I&JUYGO4)N_>J6XXIASFI]HS> M-(T/M&>]1O-CO59210W-9RJ,OV:)/,W'K2[,U"H(-6%;BLI5&-01&5IICS4Q MYHK/G9K&"*_E4GEU9ZT8HYV#@BMY>*<#BIB.*B9::FQJQXINZM M5-DNFBY]J([TG]H%>]4B":C,3&K51F4H(U5U0CO5F/5C_>KG_);WJ1485O"H MSGG2.GCULG^]7) L*>LK ]:V55HY944SM(]6S_%5Z+4\_Q5PT=T1W MJY%?8[UJJK,IT4=W%?;N]6TNO>N)AU,#^*KR:L/[U:*J9.@K'8Q7 )ZU>C<$ M=:XN'5QG[U:D&L+C[PKJI5>YQU:+Z'1[Q2AJQDU(-WJREV#WKJ55&#HR-'-) MFJZS!JD#52F0XM$F*H))<=ZR=0N,+DWF =Z M8TP'>L^6YV]ZH37^.]<\ZQO&@V:\ER!WJE+> =ZQIM1]ZSI]2]ZP=&9N M2WP'\59T^H?[58,^IGGYJSY-1+'K6,JIV0H*QMSZB?6L^:_8YYK-:Z+=ZA:4 MFL95C>%!$\]\^>M4GO'/>G%=U1F&L)53>-(%N'8U,KL:C2'FK2Q<5DZANJ1& M2<5"Y-6RE,,6:QE,<:>I57)-2A:F$.#3A'4\QKR$0%.VU+LI=M+F+2L5\4Y1 M4NRE"XJ;@T,*X%1Y.:G(J,KS4M"M853Q2&@<4N,TD@3!:D[4P#%.ILJXE(1Q M3\4E*PBO(M1A3FKFS=2>35)@0(M6%C7%-*[:9YN#5(EQ)_*6HVC%()LT[=FK MC(AQ(2E1LI%6]N:#%FME,PE3,XE@:!*XJZUO[5&;?VJU,Q=(A%PXIZWD@[T_ M[/[4AM\5:F+V=R6.^D!ZU?@U"3(YK+6+!JRB[16BJV(]A]3HX-]3!A6\9',U87 M%)3LTE;$,44M(*6J&@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** &EL4P/S225$,YH*2+0-+3$Z4ZE:R)]2R>M9=S>DYYK+>=RW6N>5:YVPP]C:EOL]ZHRW6 M>]4O,8BHV9C6#JG1&B222%J@P*RT+Y!T@+5#Y+52@CFNJ%:QQ5*-SU.WUA6 MQ\U:<.H!\K6@NU M8=:ZX53BJ4;&EFC-5EG4]ZE$@-;J9@XLEI*0-1FJ4A6#-*#49ZTY:JX[#Z*2 MEH1(4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI*!2N M%%%, MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHHN QES3 G M-2TTG%0Y(:%'%(6&*ADEVBJ,]\$!YK&55(TC3;+J$UR!GFLZYU0#/S5 MD7.K 9^:N2I61VTJ'\WGK7!4JGH0HV-" M>_)SS69/>$]Z@:0MWIGE%ZXISN=T(60HE+FI1%D9IB0%.U3AL"L7)G3"*&>5 M1Y-2;J4-6;FS51&B+%2!*3=2A\5-R[#PF*,XI/,XIA;-1=@D#-43/BE-,*YI M7+L*'R:D"YJ-$P:L#@4,3&;:7;3J* 3$Q12TA-"$Q-M&VDWTNZK:$F&VE IN MZE#9H07'4TT$TPM31,AQ-)29I:9G<6C%%**EHM#=E&VI**&BT1[:0C%2TQAF MIN,:K54A>C<*+CL(HVU.AJ'-*&Q3YF2R<\BH7CW4OF4N^ MM(S9G*-RLUH#VJ,V^WM5[>*8W-=$:AG*D5E.RIA?F/O43K562,FNB%4QE1NC M:M=:(<#=726.K;@/FKSY(V1LUJ6MZ8\#-=4*QQ5,/<]&@U#=WK3@N=W>N!M= M2SCYJW;34,XYKJA6.2IA]#L$DR.M2@YK%M[P,!S6A'-D=:ZH54>=.DT6\4H% M1J]2 UT*29BT+2TE+5HD****8!1110 4444 %%%% !1110 4444 %%%% !24 MM)28!2T44) %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBBD E%&::6%1)C$9L57EG"]Z;/,%'6L:]O=H/-*%/-<[? M:AUPU5+[4SR-U8%U?EB>:X*E8].AARY5BG!]M97-DBS*%V M\52;.ZIC)NINW-1(N*L,&:7FGA:>$K-FER'FDYJ::>:I(ELA.N:% M&:>%I\H"'I49!S4^*-E*PKD0I:>1BDQ29-A!2YIC<4@;F@I$N:7-,'2D+4KE M(EI*:#FE-0RP-,-+FG;>*3*1%2TI%*!2& I]-Z4F:30#J.U HJ21C9IF34VW M-)LJD*Q#S2@&I0E/$=4D)LC%-;-2$8IN,TR=R')IVXTYEIHZTTRDA033P: M M!XHYA\MQ",TT(*>.:4\52F)Q(I$&WBJ#[U;BM$_-Q0;8-SBNB%4PE3(;:=UQ MDUMVEZ1CFL5H]E-%P4[UU0K=#EG3.YL]0'&6K=MK]2!S7F4.HE3UK8L]5.1\ MU=E.H>=7HW/1X;D-WJXD@-!0>:YR_O\ K@UR5:UCLI4.8O7F MK 9^:N>N]5WD_-6;>WC$G!K':9R_6O/J5;GJT<.D:-Q.9#UJA("33E8DX$PJ0&H1TIV:B0R0FHR:,TUJ5AI@33<44X"CE&V(#BGAJC(I5HL M%R0FF[J0]*;S0T"9)FC=312&FHA>E#0)C,TX&HSUIRU/*)LD!I:92 MBJ2%S#J7?33TJ,YS5J(V/)S29Q2"D:AHE"DYI M(.M2=JAHL0'%(>:0TX5+* M$'%!.:#2"E<-Q .:F#@"F8XIAS51E8AH)?FJH\9JV!04S71"9SSB45C(-6H& M*&G^736&!793JG-.%S9M-0\O'-;UIJPX^:N",C*W6KEO=.I'-=,:IR5*"9Z; M;:D'QS6K#QTRMD4[-4(+I2.M6E?=TK MMA.YP2@TR<&EIBTZMU(S:%HI*6J3$%%%%, HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@!I% 6G44 %%%% !1110 4444 %%%% !1111< HHII-2V,0FF[J:S55 MEGV=ZQE,TC"Y8ED %95Y=;5/-076H!0>:P;[4L@\UQU:R1V4<.^I'J.HD$\U M@7%Z7SS4=]=[V/-9QDR:\ZI5N>I1HV)G;?4)CYS2@T_.:XY5#T(P&@8J1128 MI0<5SRE*3-&ZA A:,44 MA.*=Q)"XHH!S0:+@T%%,W:6=[AAS75:?J6 .:]'#UCRL3A[; M'8AA3@:R8+S?WJ_')FO0C-,\V5-HLT4T'BES6JD96'44S=2@U:D%AU%%%4(* M*** "BBB@ HI*6@ HI** N+1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !24M,8 MU+&@+4QFIC/BHGE '6L9S-%$264"L:_NPH/-3W=T%!YKEM3O>&YKBJUCNH4M M;D5[?\GYJPKB[+'K5:ZNR7/-4Q(6>O,JU+GKTZ9,^YS30A%7((PR\TZ2("N* M4SLA"Q3"FI%%2!*7;6+9T)" <4TBGTN*A%(8*=2D4"AB>X4N:0TS/-"*2!J M*]2XI"*+@D(#Q3&IGCI2XI M*JXA&I!3\9HQ30A.U,I]&*>XDQ!TIK5)28JD(C7-248I:&(;2T4G>@6PII,4 M]:4BE<0REIIIPH*3"FL*=2@9H8[V(@#FGXXIY6FFD@O4=QHI:7%+3L2-S3&-*QIHYJ1VL.3K5@=*@45*II!N(RYJ%UJUU% M1LM5S"L4'4TP!@:NF,&D\H5<9BE 9"[*>M:MI?%".:RW7:*K&X*/7=1J6."O M3N>AZ??@XYKHK:Z# ?*G8L9YIZU$IS4HK9,S8\4M)2UM%F844450!2&EHH ;2T4M DAM M***6F%@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "D-+2'I28#U,84(FP[.:,TT4'I03U%W4 MW%&*=VHV&V .*=G-1DE,QS1N)D@-+G%(*#2$QV:*: M*4]*M"0TM1FFXIPJK"8X&ES3:6A"$INZG&F8J@2'@T$T@Z4&F@ &G4P"G4,3 M$S11BEI)D[B@XH+9III*3"PIHS11BBX;"@TH.*;0:5Q]!^ZD--%+5($)FE!I MF.:*7-($B M424N[-5^:D6DQ#B<4FZD:F#K2B#'N,BJ,D/S9J\#F@QY%==*1S5(W*T+&.MF MRU#9CFL:1"*8KLO>NZG4.&I2N=_9:INP-U=!:W&\#FO--/NF5ADUV&G7PV@9 MKMIU#@K4+'71-D58!K*MKD,!S5]),UVPG<\NI!ID^:7=48.:6NF+,K#]U.!J M,4\5HA-#J2EI#3)84M-I10)"T444#"BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ;BDZ M4I-1.^!6L>\NPH/-/U"[V \URE_J7)&:\ZO4LST,/1N2W]]U& M:YJ]N"Q/-)=7VX]:H-)O->=4J7/7IT;(BD^8U+!'S4L<.ZIO+V5RRE1TQ'.,U">*FSFF,M8,U0Q34H%1@8IX:D4AU-Q2TTF@08 MH H!S2TTR6@Q24[-)BJ!Z@!0>*7.*0F@+A1B@49HV$F)2XI*3=2L-#J*;G-* M*0,7%%&:2FQ7%Q1BFYQ1G-(?06EQ24N: 3%HHII:CE'<6BFAJ=4M:CN&**,T M4-"N%(:3=29S3MH-, :E*&H2&W:;BF*XJK2XQ0*#2M< M38E,88J2FD9IY!P:XZ[N"SGFK^H79;/-8A M8L]>3B*MV>UAJ-B)@S-4D<9S5B.($5.(P*X74/1Y+(6'"BG3$$<5"S;>E"-N MK-LI1(&4YI5!%6R@Q43+BIN4E8%-/ZU#G%/4U+1JA6%,Z5+3363128F:0TF> M:>M(8BBG=J**$R6)2TM-K5(G8#24^D-%A,2DI12T,$A*C(I]*!2N"& 4ZE(H M%)@Q*#3J:: L,- I^*,4^@7"BBEH2$':HS4E)BJ!,8*?1BEI6!L2BEI*30## M0*?BC%'0=Q"*;CFGT['%"&A!TIK"G44D.XP"EIQ%)0R6,QS3QTIV.*2FRKC6 MI *?010A"=J9CFI*,<4[B0@--;FD/6G+S2L4(HIYZ4N**3&1$W&37/E,&IX9C&:[:QO00.: MWX)PRBO.=-ON1DUUMC>!E'->G1F>37HG2(V14@JG!*&'6K2FN^#/,E&S'T44 M5L0%%%% !1110 4E+24F@%HI*6A, HHHI@%%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %(3132:B3&AK-BJ-W-L0\U+/+M M!K#U"\&TC-:?J=5J79Z,*=AR\"E+TTTTBLKG0D#?-0ORTHI#2;"Q M)YE(3FHP#3^U(&1GK3TI"O-*HQ0V4AY/%,S2M30.:D!<49Q3L<4PCFDAW'@Y MH)IJTIZ46U"XFZES3,&G55R6&[%*#FFD4H%- ]AHXJ1W$Z4H:D84@'-5T DIA:G=J80#32*4"G<=AQ;%)OS36Z4T#FKW)L2$\4POS3NU1%3FI M$W8E4;J1UVT^+CK1-R*&4G@YK M8BDS7#Z9? #-=/9W&\#FO3I5&SQ*]*QLJV:?5>-LU.#7?!W."2L+244G>M2 M&Q:6D%+2&A":;FE/2F8YI,I$@I:04M")"BBBF 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !24&FDU+&D.J&1P!3\\5GWD^P'FL M9RLBX1NRIJ-P%4\UR-]>Y8C-7]5ON&YKC[J\S*>:\RO4N>MAJ5BS.V_-9LR\ MU.LNX5%+S7D56[GM4H61'$.:L]JK+Q4RM7*SKBM!W>C%%-+4D-(1J%HZT=*! MC\<44T-3J3$T*!24TMBC.:?0&.I<"F9H#4($/I,4M,+5)0ZBF@YHS31/4?@4 MVDW4ZA@T H--+8HSFGT![#A2X%,S0&H0(?BC HSQ32W-)#%-%-SFC-!/4?@ M8IM)NIU-CL**#3"<49S0 ZEP,4S-&ZA AU %%(3BD@L*:04F[-&:8GN/P,4V MDW4ZACL %!%(3BDW9HZ!T%IV!BF9HW4($.H H%(3BD%A&IHZTN*;UH)S0*EA% 4%-QBI::121NF)NQ3&^:D-.49 MJT#L,\L4X83D4YN*KROBNZB<5:QIV=X5D S7:Z1<[E7FO-+>4^<*[;19SA:] M2BSR,2D=U ^15Q>E95F^X"M1.@KU*>QXU1:CZ2E[45LC!H!2TVEH!,*,4M)2 M8PI:2EI( HHHJ@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ I":6FM2;L"$)IAHSS378!36;D6D123!0>:Y_4[T 'FK=]<[0>:X_5;T\ M\UPUJO0[Z%&[N4M2N]Y;FN=DRTF:L33EW/-,5,G->;4D>S2IDD72GL*$XI^, MUY\WJ=\-$1;:>HYIX6E-8,V0=JC(YI]**07(P*4BG&BEU%U& 4^EXI*&.XPB M@"I!2>!C2*0"GBEXH0(2F$4^E%)!*"*?0&-INVI*7M0@0@Z4UAFG4"D@N, I:<:*!/Q)Y>:,;:M1@;:K7! K:,3*4 MR"1ZK,-YH=B34UM&7;I7=1BD6I 7BL_3K')!Q77Z=:!0.* M]&C$\C$5#0LHRH%:J]*KPQ[:LCI7I4SR:CNQU)125NC)L*6BEIB2"DI:*EHH M****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M)333J:364V-$3\54N)MJ&IIY-JU@W]X%4C-JWF-W-<=?W18G MFM35+K<3S7/29Q0I61%&=SUH)'\E5(HBIS5X-A<5PSF>E"-B!C@U+ M%S43C)J6+BN>6IJM![<"H=W-3.E# MW*&[J,TFVEIL3#.*4'--(S2J,4= 0ZF[J<:9MI(8N:"<44A%")ZB@YIU- Q3 MCTH>Y0W=1FDVTM-B89Q0#FD(I0,4= 0ZFEJ=3"M)#%S1G% %(1F@GJ*#FG4T M#!IU#*&[J,TFVE IL3#.* *85YJ1V)XC1+TIJ'% M.8[A0F%BJ>M/48IWE\T'@5M!7,YLE$FT54GDS0\F*B^^:ZH0.:E3@ M>/5J-L55Q3J6BNJ*LU3IV1(R +4!/-6W^[5-OO5S.5V=,8DJC(I3Q35-*:OH2Q M0*::3=0A(=2BDII.*2"PXT4T'-&:!=1_&*2F;J?38[ *#32<4 YHZ .I>,4 MS-)NH0(?0**:3BD@L.-%-!S1F@3W'\8I*9NIXIL=K@*#32<4 YHZ .I>,4RD MW4($/H% Z4TG%)!8<:*:#FBAB8_C%)3-U/'2FQV 4&D)Q3,4RDW4($ M/H%(*"<4@L.-)3-U+0Q,?Q2&F;J<*;'844III.*3=1T =2\4RDW4($/H%(*" M<4NH6'&DIFZEIL&/XI*9NIPH8;BBE.*:3BF[J 'TO%,I-U"!#Z!2 YH)Q2ZA M8<<4E,W4M-@QXQ2&F;J<#FA@**#2$XINZA#6@O>G@<4T"ES4-EK4:QQ3HSFF M'FG(<41025B<@8J"7I4N[BH9#D5UTXG+-E"0G=5FUB+D<5'Y>YZW=,L]Q'%> MA3@>?6J&CI-GDKD5V5G:*J#BL[3K/;CBNB@CP@KT:4#Q<14U'1IM%3BFXP*, MXKL@K'$]22BF@TZM26%+24M4A!1113 *3-(QIF>:=@):*0&EI %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 444A- "T4W=3J "D-&:0GBHD[#(I#Q6 M5>S; >:O3RA0:2AB8S;3QTI>,4E-CN-(S2;:>*#0 W%)MI]+QBA M AHI",TZ@4@N,V\TM/-)0Q,9MIPIW%(:;'<0C--V\T\4IHZ ,Q2;:?2T($-' M%!&:6BEU"XS;2XIYI*;$QFVG"G4E#&(1FF[:>*4T ,I-M/I10@0T#%!&:6@4 MNH7&;:6GFF]Z;!C=M. Q3ABD-# 0\TT"GBE(H0UJ-S2&D-)4M&BT"ESBEQ3' M.*T@B9O05GP*C#[FQ43OFG6\;-(*[:43@JR-&VM?,8'%=7I5EC'%4-+M,[D-(D!I::O2G50F-84S%2TTBFF(:#BG@U%WIZTV@'T4 M45(!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 )1113)%HHHI%!4+MBIJA=MA*6A%.^XYJFS\U,YS55ID?%3=:\]O4[HH8.M/) MXI,4A-5%A(86YJ1.:CQDU*G%=">ASR$?@5$#S4S\U%MYH$AW:DW:?30M.H8#2<4H.:0C-*!BGT #3=U.--VT(!:3=2TFVDB M4.!S0: ,4&CJ4-W4M)MI:;$Q-W-.4TW;3@,4/8:%)IFZG&F[:$ M)NYI<4FW MFDB4*#FG&D Q2FCJ4,W4N:3;2XIL3$S2@YHQ0!BCH"''I3-U//2F;:2&+FD) MI<4$9H1*W '-./2F@8IQH>Y0PM11MI<4Q,;G%.!S01F@#%'0:'&F;J>:9MI( M!Y0S=2YI-M+BFQ,0FE!S1C- &*.@(=3"U/IA6 MDAB@T$XHQ01F@GJ .:=30,4ZAE#-U+FDVTN*;$P)Q0#F@C- &*.@(=3"U/II M6DA@#2$TN*",T$]0!S3J:!BG4,H86I0:"M&*8F!- .301F@#%'0$.IA:GTTK M20P!H)H H(HZD]1-U.IN*,TV-ANII=C@*=1178DC&[,O5KD'/-[AX6)B:O2C845*M1BG9KE9UI:#STJ(]:<33351):'"G"HP:>*Z(HPDM1324-3.E-CMGIN85 MV4XG-6GH:VGVN2.*Z_3K; '%96F6O"\5U=G;X4<5Z-&!XN(JV+EJF *N 5%& MN!4PKTZ>QY$W=A0:*::Z$C)L,TX4RG"G8F+U'4444%A1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11128#&J!FJ9ZJ2MM M%<]1V-8(CNI,1FN'UJXP6YKI[ZY C89KA=9FW,V#7%6EH>AAJ>IBSR[R:KJN M31DEJEC%>559[=&%B1%XJ8)0BU,!Q7F5'J>A @*XIM2O46:RL=">@4E+0!5Q M1,F 6GCBE'2BM4S&0TC-)MIU*:&P6PVDVYI:<*FX(9BC%.HI"ZC0M.I2:;0Q MMB%U"!"4TKFEI0:2"XW&*,4XT4"ZC0M.I>U-IL;8$9I, M8IP-!HZ -Q1MIU+VH0(2D(S12BD@N-QBC%.-% NHW;3J7M24V-L0C-)MQ3@: M#1T 04N**7-(20VDVYI:44(%N-VXHQ3C10QL;MIPI>U)387$(S2;<4X&@T= M&XHVTZE[4($(*0C-+0*07&[<48IYI*&)C=M.%+2&FQW$(S2;<4X4IHZ ,Q1M MIU+0@0T4$9I:*74+C=M&*>:2FP8W;2BG4E# 0C-)MIPI30@&4FVGT5((04$9 MHI1307&[:6G&DH8,9MI0*=12N#V&D4@%.I,U:)N**&Z4A-,+]JZ*<3*4BM*N M6K6TB'+#BJ0B+FNBT>U(9>*]"E \ZO4L=+IUOA%XKH;=<+5"RBP@XK4C&!7H MTHV/$KSNR8"G"D%.KN@CC8E(12DTF:V):&T\4E**"8H6BBBD6%%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)114-C&-5" M];:A-7G-9.IR8C-'FL1VW&O*K3/;P MT-"MMYJ>(4@2I47%>=4D>M3B3J.*":0'BD)KA>K.J*(W-1$T]Z9C-(TN*.M2 M@4U5J052(N-HI2*83BK1# FDS1UI=M#&@IN:?2;:2$A5H- &*",TNI0S-.HV MT8ILEC:3;2CB@H4]*CSS4AYINV@ I">:7%&VDB4"G-*>E &*4\T=2B/= M3J-M&*;$Q">:53FC;2@8H>PT!Z4S=4AINVA %(3S2XHVYI(E IS2F@#%*:.I M1'FG4;:,4V)B$TJG-&W-*!BCH"%/2H\U)3=M)#"D)I<4;:?30 MN*=0RAA-*#1MHQ38F(30#S2XS0%Q1T!#J833Z;MI(8 TA-+BC&:">H@-/IH7 M%.H90PFE!HVT8IB8A- /-+C- 7%'0$.[4PFGTW;20Q :":7%&,T$]1 >:?3= MN*=0RAA-*#Q05HQB@3$8TS=S3R*9BJB0WH#'BH-QWU,W2HT3,@KMHQ..I.QK MZ?!YF.*Z[3;3;CBL31[?.WBNSLX, <5ZE*!X^(J%^WCP@JVHJ-%P*D!KOA&Q MY*6FBG5T13,V,8TP-S3WJ(#FM2&3K3J:O2G4B@HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0TA-.J)S6>]48^:=?N6E/UI(! M7DU9ZGNT(61*!BE!H;BF \UP5)7/2IK0DS2%J#TJ(DYKG-16YH6@*I(38I-1MS2$TY>:&,1>M29XIAXI : 'T BCM49/-3<+$F:,TP& M@TT3U),TE,!YI]#*L*#2$TPFE!IB8ZER*8>E(#0"'TH-)VIA/-)#L/)HI@-* M>E!/4?D4VF9I].PV*#033": :&'0>*=3*44KB3"@44PGFA#L/)H%,!I356%U M'YXI*C!J0=*0[ *"::QI : 8^ESQ3*;FA B2@4#I36-)#L.)HI@-+02]Q^1B MDJ/-2#I395K@*"::QIH-'01(*7M3112$F*: :2FDT(%N/)I*:#2T,&/R,4E1 MYYIXZ4V586@FFL::#0(?3LC%,IN:$")*!2#I2,:74=AQ-)3 >:=39+'Y%)4> M:>.E#*L**4FF-2 \T=!#J=FF4W-"!$AH%-'2D)I"ZDA-)3 :?0QV%S24PGFG MK3 *4FFM3 >: 'TX&FTS/-%A(D- IH-!-%@ZCR:2F \U(*!V 4AHHH%<::83 M2O4+-6D%J93']35FW@+..*K0_,U;VGV^YEXKTJ$3SJ\C=T6WP%XKKH(\**Q] M+M]H'%="BX45Z]*.AX5>>HN.*3'-/HQ70CFN"T^FBG5M%DLC>F#K3VJ,=:H1 M,M.IJTZ@ HHHH **** "BBB@ HHI*38"T444P"BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "D)HS32:!I!FG"HQUJ1:0V@-12'BI35:9\ UC48XK4Q=5EV*U<3J-WN M72BI PQ699#MQ2%:E)IF::86&%<4W-/8TS'-7<+"@9IX%"BG5 M#8QI&:;BI,4$47$-II7-+1F@28@&*,9I:!4W#J(%IU%)5;@V(10!1FC-7T)N M+C-)MQ3LT$TKE(9NI<9IN.:D44%#<8H(IS&FYI$,3%.I12XJQ7&$4 4I.*,T MF%Q0*,8H%!-)(I(:6HQFFGK3UH&&,48S2DT4$]1NVG4N>*;0-@1FDVXIP-!- M =!N*-M+2YXH0(*0C-%.%(+C-N*,4\TE#$-VT9Q2DTP]:%J6.ZT;:%IQ-,3$ MHHHS0B I,9I:44GH-#0M.Q2T4KE6&;:<*,TE%P8$9I M+FES1< Q3=M/I,T7 M"P@H(S12BBXANVC%.-)1<&)MI12YI*!L",TFVG T$U700W%)MIQI-U")N&*, M9I1S2]*3&F(%IW:DS2U-RQA6E'%.)IAJDQI"GFDVTJT_%4*0RFD4_O1CBF9C M.E'6AJ5*=M"D 6GBEQQ3"<5(,?BFFF^8*-V:+">PUN:A<8J8U&PW5T4U5D:T%>1RFN2G:U<'<.3.:[36FR&KBIA^ M_->)7D>Y1IEN \5/4, ^6I2:\RH]3T8+0:U-%/ZT;<5SLWB&>*;NI:3%2=$6 M*#FD8TG2CK0@:&@\U(!3=N*4&J:;$.HI1TIC'%3RL"5:<>E0JW-/W<5:1,AC M5&3S4AYHV9HD)#5I]&W%!K,L3-(3Q2$XIFZKB9@3S3EI57-2K'6B%:DQ2;:2 %I30!BEQ0#0V@TN*3%4B!F>:<.E+MH MQ3L-B$T \TN*7;BJ0=!#TJ$DYJQC--\JK2,Y"Q]*'XIP&T5&YJ)(<1%/-2]J MA7K4X'%9/*@9Q2?>-9M6+O<@9CFI8R:F%OGFD,>RI(; M&,<4L7S&H9&J:S^9_P :Z:*.2JSWA MHGAXR1I*N*=117I):'EB4M%%)( HHHHLP"EHHK1""BBBF 4444 %%%% !111 M0 4444 %)2TE F%+3:6F),6D-%-)H+0$T"DZTX"AC'44E+21(VB@T4R HHI* M %I:*6@I!1112&%%%% !24M)0)A2TE+0""BBB@84444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "4M%%2@ M"BBBJ **** "BBB@ HHHH ;2T4E,D6DHI: 4M%%(H*2EI*EL HHHJ%<8M%% M%:H04444 %%%% !32*4T5+8T,QS3A2XH/ IA3F6M2]G+,>:RCR]>'6EJ?048ER(_+2LU,CZ4C& MN&6IW11*AJ4]*KHU2[Q24;E6$QS2XXHW"C<*;IE)C2M*JTX$4N10J1IS:"$< M5'CFI-PI"16JID.E-H!U=<:9 MRSJ%+R"33OLK$=*V(K,GM5M+#/:M%3.=U;',M9MZ4W[.4KK/[.X^[5&ZLMH. M!0X#C53,'I3HS\U230E2>*B7(:N6:L=,)7-.+&VH+C%+&_RU#.]8EM%*4\U; MTU=T@^M4V!8UK:/"3(..]=U")PUW9'8Z5!\H.*ZNS7:HK'TN#$0XK!B)\S+5%-6GUWHXF%)2T4[""BBBF 4E%)3%<=12"EI#"BBB@ HHHH *** M* "BBB@ HHHH 2DIU-- K"9I*3O3P*$R]@%+114MB"C-(:2A$MBTM-I:LD6D MI:*!V%HHHI%!1110 444E)L!:***8!1129H 6BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $I:; M2B@5Q:***!A1110 4444 %%)2TDP"DI:*8F)2T44 D%%%)2;&%%%%2,**** M%HHHJD(****8!1110 4E!-)FDT M(_2EIDA^6IN-;E"ZDPIKB];F^]757TF% M-<-K'5>I[U&.A*@XH84JT_;FN8 MZK6169MM,,U6'@)[5";4^E=-.%S.4[#//-+YU.^R-Z4?9CZ5O[*Y"J(3SS1Y M])]G-'VR%[8 M8LQ-/\XBA;1AVIQMCCI3='0:K##?4B2YIG MV8^E.6(K7-*F:>T+*M3]]5]V!0'J.0?.6",U"ZT]9*=C=46%S(A1.:EV<4X) MBE)XJ&:19 _%5W/-67JJ_6G%&SEH/1L4YI.*(HBU2O;''2MX1U,)315\WFG" M>D,!S2BW-=/(9^T#S=BG"V/I2&W/I4RB6J@])-U3!>]0I$5J<'BL'$M20 MM-QFES1FLV"8 8H(I:8A>M.VTBT^@38W%+2$XIN^J6A ^D*YH!S3P*4MA MQW&JN*G%=5;VORCBO1I4[H\RO6LS-AT_VK0BT_CI6C%;X[5=CB '2NI43SJF M(9C'3QCI6?=Z=D'BNK,8Q52> 'M4RHBIXEW//;ZPVYXK FCV/7H>HV>0>*Y' M4+(JQ.*XZM(]?#U[F/YN!4+RY-%P"AQ58-DUR.GJ>DI)HT+>+S#73:39X93B ML334R179Z9" %KKH1U/-Q4M#H+"/;&*TD%5K5<(*MBO8HK0^>J/4>!3J0&EK MM6QBPI**2J)8M%%)0*X4M)2T A:***104444 %%%% !13*6D%+2)"BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2BEHH%8* M***!A1110 4444F E%%%2,6BBBK$%%%)0 M%%% "44M)46 ****8"T444T 4 M444P"BBB@"-J:M2$4@6@!>U1S'"&I:@N#A#64RH[F!J,F U<'K4A.ZNOU67& MZN)U)MY->3BI:'MX6-T8<>3+^-:2+\M5(H_GK15?DKQ9O4]RDK(@_BJW"F:@ MV_-5^U3.*F*U-)NR)$MMW:IEL,]JU+.UW8XK6CT\;1Q7J4*5T>57Q"B['+&P MX^[436!STKL?[.]J:=,!_AKLC1.1XHX_[ ?[M(; _P!VNQ_LP?W:4:6#_#6B MI$O$G'+8'/W:E&GG^[77#2A_=IXTP>E/V9'UDX_[ ?[M2+I_^S77#2QZ4O\ M9H':FJ8GB3D&T_\ V:9]@/\ =KLO[-![4G]ECTH=,%B;'''3^/NU$VGG^[7: MG31Z4PZ6/[M<\Z)M'%HXO[ ?2J\UF1T%=L^F@?PU5ETP'^&N2= UCBD<+) X M/2J[1L*[.XTK'\-9-Q8;>UY@@D&KD)&.:2:#8>E5S)LK"4#:-0O. M1BJY;FH1/NIX.:PE'4ZH3N//2JK*2U6QS2I#N85<(BG4T+-C!NQQ6B]GE>E2 MZ;;=.*W19;EZ5VTZ1PSQ%F9!71Z9#]VNZDCAJLZ+2[<#'%=/!"-HK(TZ+&*Z&)<**]G#QT/!Q,W<5 M8P!3P,4X4&NSD.%MC:8R@TK&@'-*4$"9GW=N&!XKF-5M %)Q79RKD5@ZI#^[ M-<56F=^&JV9Y=J:;7-9\?WJW=8BP[5B 8:O/E#4]V$[Q.BTE?BIFK ,)4U1Q#BI@*]&DCQI/45:?30*=74C-A244E,E MA24ZDIDB4M%+0" 44M)4LL****D8444E*X#32K1BE JDQCJ***HD0U$W6I33 M&%)@(IJ3M4?2G TKCL.H-%%"$1-2K3BN: *H!PI:** "BBB@ HHHH **** " MBBB@ I*6BDP$[4TT^FD4T-#13P*3%.IL&PHHHI""BBB@ HHHH **** "BBB@ M!*6BBDD 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH ****& E%+14V ****H!#24M%,EA2TVEI#3%I*6BDQB4M%%"0 M!1113 **** "BBB@ HHI#28"$U5NGQ&:L,:H7K?NFKFJ2-8*[.1UF7!:N0NG MW$UT.MR89JY>1MQKR,1(]["1T&Q#YJN9PE5(Q@U,[82O)DM3VH+0;YGSUKV/ MS8KG/,_>UTFE?-MK6G&YC6E9'5Z='TKH(HQM%8^GIP*WXE^45[N&A[I\UBY^ M\,$0]*7R1Z58"T[;7=&!QE.$0]*L;:3%-QL+G(O+%'EBI<45FQ7&;! M2%!3Z*F]@N1A!2[12FD%.]QC?+'I2%!4O:FD4I1N-,KO$#VJ$P#TJ[@4;16; MIW+4VC)GM01TK'N[#(/%=88@:K7%L"AXK&>'-85VF>=7MD1GBN>NXBI->B:A M9\-Q7(:E:$$\5Q3HZGI4JMT8$>A<[:[&)1L%>A3B>)B*C4B%81Z5*( M1Z5,%J0+79"GFNVUH M?*U#3%Z4&N":/7ICCS2"A:<:YV="8N:*9WIW:I: M!B$TF:.U0Q(7-)G- M-.:%I&R'BG9XI.U-[TRA32=*<.E,:A,EBYH'6FBGT,S:'YXIA%)FGBL[V$T( M.*4FD--IIW!(6C-(:;S6T"K#L9IPXI5Z4UJTN,4G-, YI13L5#8P!HIIZTX5 MFQM"44II*$S-BBG9XIE)51944*32 XI"::32DS05CFH66I5!-*Z\4HNS,9JY M%"<2"NFTP_=KEE.)!71Z6_W:[Z,CAK1T.UL&X%;L;?**YRP?@5N1-\HKV\/+ M0^>Q,=2X#2]JB4U(*[DSB:&,*%&*?BDQ4MB&/TK%U0_NC6Q*<"L'5I/W1KGJ M,ZJ"U//M:<>8WUK# W-6EK+YE/UJA;+N85R..I[U-VB=3H,?S+7H-DG[M:XG M0H^5KO;1?W8KKI0T/*Q*ZHJQYK8M%%%:HD2DIU)3$T%%)2TQ M!2T44AH*:32FHVJ9%)#P:,TU:4U([!FEJ,=:D%*P,6BBBJ0A:0T9IC.!5-@D M*6IADJ)Y@.]59+D#O6HC?+_>K+VFIK[+0VEF!J=6 MS6#%> MUK4MY@PZUI&5S&4+%REIJMFG5JC(2DS2FF9JDAI#Z6D%+2$%%%% ! M1110 4444 %%%% !1110 444E !1FDHIDW%S1244!<=244E VQU%)2TAA111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%)2T MDP"BBBF 4444 %%%% !1110 4444 %)124R6PI:*2@!:6DI:0T%%%% PHHHH M **** "BBB@ IK4ZFM4RV&B)C6??-^Z:KDQVBL34+H!&&:XJC.FE&[.,UU_G M:N=7YC6UK#;V:L9!@UY%>6I[^%C9$H&*CF;"U)GBH9AD5Y[W/46Q1#?OA]:Z MW1>=M!6[&/E%8FG=!6[']T5[N'6A\WBG[ MP^EI**[$<;%II(I2>*I7-R(\\TI.R&E_M<9^]4BZJ#_%6+JHKV,C MICW=MN!XKF=1L,YXKMY4R#6'?0@@\5R5:9VT*FIY]=VGED\5FM\K8KIM4CV[ MJY:=L2&O,JQU/9HZHE#\4Z,YD%55>K5N,N*B**J7L=GH)^[7:0GY!7&:&N-M M=A%]P5W48GB8A>\65J05"IJ9:[H(XY 1Q52<<&KAZ54GZ&BI'0JGNWA-A%-.QFH5:IUYKS9H]BFQ.E**?MS36&VL M'$ZD] Q149DYI0V:AHF4A^W-(5Q3@U(QS18SG8$R2C%*HR*#Q5 M(8TT"@\T#BADCMM-(I^[BFFLV-";*; MUIY7-&VFHDR&XI:1CBF;^:31F/I@XG% YI!\U/ Q6W**XF,44I--%+E*0N*;TJ04TK630TQ5YI2*9G;2ALU- MC*3U$I<<4N.],9L4TF.+(W.#0G-(PW4Y!BAHTYE8F1:)%^6E5J)#\M9]2'J4 M3Q)6SI\N"*QG^]5NVFVD5V496..K&YWNFRYQS71PL-HK@].O@N.:Z:UU ,HY MKV\/-6/#Q-&5S>5JF4UG13[AUJTLE=T9GG3@T6:3-1>95>6Y"]Z;FB%!L6Y< M &N9U:?Y",U>O=0 !YKE=3OP0>:Y9S1Z&&IM',ZHVZ4_6H[-,L*KWD^^;KWK M2TR/>16*E=GJI6B=?H:!I#&:J\TN!UJ63BLJ^GV*>:PG.QO3C<9<7>,\UE7%_C M/-9M]J>UB-U9$VH[L\URSJ'H4Z2-*YU0KGYJI#5R6^]6+ MIG]!6]']T5@Z=VK>C^Z*]O#K0^=D;48W9S5Q>L'/-56OV_O5 M6NY/WC51>7FO'J5;,]:G2-/[>V?O5/%J#?WJP?-H^T$=ZYY53I5"YT9U _WJ M5+\Y^]7/+=$]Z=]I([U4*I?L$CKK;4.?O5NVEZ&QS7F\-^0_6MZPU DCFNZE M.YS5Z6AZ##(&Q5M:P=-N-X'-;R'(KT:>IY%169)10*#718P&..#67>)D&M5N ME9]R,@UE46AO1=F<5K*8#5Q-V")#7?ZRG#5Q%Y'^\->566I[^&EH4$)W5J60 M^9:S@OS5IV7WEKGCJS:H]#M-&'W:ZN/[@KE=&_AKJXA\HKT:*/#Q'Q$B]:G6 MF*M2@5VJ)QR8'I5*X/!JZ>E9UV< TIJR"GN/B3W<+L5D/-6HS54#!J9#BO,EN>M3+JD5%.PQ47F8J-G+5%KFKE8A9CNJ M5&XJ,HWN67'-;M ME?XQEJY8$BI!=-'WKTJ-T:);LMWJE*Q:N5R.^$;%!BS3#ZUU6AQYVYKGHXLR#ZUUFC1XVU4'J;R>A MVFFH !70Q?=%86G]!6[']VNZDSPL5\1)2TE&:ZE(XQU&:;FFEQ5*86),TA-1 M>8/6CS!ZU7.'*.-**;N%)O I-C)8/6H8*>"#3B[A M:P]:?3!BG9K9$L6D-+13$1F@4XTE3)V*()NE=:K<.)3SWK.$KGO6AJB9F/UJG'%7GU*AZ]&F0L2:?%G-/>/%.A3FL MXU#6=+0VM)'[P5Z)I*CRQ]*X+2UPXKO=+;""NVC5/(Q,&C6QBG"FJ0:>*[(R M.&0X4\4P4X$5T1D9V'4F:">*B9JNY25R7--;I3$;-2=10)JQ#SFI5HVTHXJ; MV =1244[B%I#1FD+"BXQAZTHH)%)N%9R90_-&ZHC(*;Y@]:R]H"B3YHS4'F# MUH\P52J!REC-%1*XI^ZK4Q-#J*3-&:I.XK"YHS3":4&J3"P^BBBJ$%%%% !3 M32TA-*XT,[U(*CR,T[<*GF&QV:,U$7%*'%"F'*$E0#.ZIV(-,V\T[@B5.E.I MJ\"@M2350=:\FH>]2)LYJ-QQ3EH?I647J=,MB"/_6"NITD9 MVURR#]Z*ZS1QPM=])7."N]#L-/' K?B'H=>%C>1Q=R^9&^M566I9O]:?K2$< M5X=:6I]+1H715;BF8)J5UYI56N9R.I44B(#%#&IF2HRAIQD[C=)6(UR&K3LI MRKCFJ&VI8 ?,%>A1FSSZ\#T+19\A>:ZV%LJ*X;0R<+796[?**]BA(\'$0U+X MZ4&FJW%.KMZ'%88U5)AD&K35#(.*YZC-(.QR>LK\K5PMZ/WAKOM;'RM7!WO^ MM->57>I[6%D[%#'S5?M.&%4?XJNVWWQ7-"6ITS>AVNC'[M=;#]T5R&B_PUUT M/W!7HT9'C8C&S!7I5D6 Q]VMU2/.J54<6VFGT MIO\ 99/:NR?3_P#9I4T\?W:'2,?:HX]=.*=J>T>P5U%S9!5Z5AW<6W-8RA8[ ML/4N9,AP:A,E.N#@FJN>:YIH[XZEI6S4@J"(58[5BRVA"U,)I#24C(D6D8T@ MI&JHHM.R 1[S4JV!;M4MFF]A71VMCN3.*[Z-.YRUJW** QKAJ0.RE5N48QBGN>*04R0UCR'1SBQC+5?BMMPZ51 MMCEZZ.RA# <5V4*9S5JEC/\ [.+#I52;2S_=KM8;($=*273@?X:[E3T.%XC4 MX9-+)/2K46EE>U=9'IHS]VISIX ^[4RI#6)U.4^R%%Z50N(L&NMN+3"GBL*[ M@PQXK"5(W5?0Q#"34D=F6/2M&*V+'I6G:V&<<4XTC.5V( M[57>+%=#!6JAPM=L'9'B8C5D^:8TF*CDE"K6;<7ZKWI^UL8QIMF@\X'> MJDMX%[UERZFO]ZLRYU$'.&I>V.F.'T-QM3 /6H_[5 _BKDY;\Y^]5=K\_P!Z MG[8TCA[G:_VN/[U)_:X_O5Q']H-_>H%^W]ZDZXUAE<[;^UAG[U*-5!_BKB?M MY_O4]+\Y^]4>V+^K([==2![U834!ZUQ27YQ]ZIX]2P?O5I"L8SPYW45V&[U: M63-:SI-04=ZYZE2R.FG1N:<]SQUK U2XRAYI)M0#=ZR;VYWJ>:\FO6/2P^' M.H4!%>>ZMV>Q3I60]AFG1)@T"I5P*.8M84FI+C[U1PZ@&?K77"J9^QT.J23<*1N:I6DX=1S5T'-=2G M='.X\K%6I0:BSBE5ZT4B7J34E(#Q2U+=R I":C>4+562\5>]1*=BE%LGEFV] MZI27P4]:I7>H+@\UAW&H_-]ZN>5:QV4J',=(=1'K49U,?WJY-]2Q_%5=]3_V MJPEB&=:P:.P.I#^]2?VB/6N-_M/_ &J=_:G^U6+JLT6$1V']I#UI/[2'K7(? MVE_M4G]H\_>IQK-@\(CM4U$>M6H[T-WKAX]1_P!JM"WU$IA)GO7.P7ZGO6E#M)]M'K7-2ZB WWJC_M M(?WJY95K';'#)G2M>^]1G4 .]J8XC4)8=)'9P7PD/6KZ-E M:SE5L5"E!>]0'41ZUA7-^!WK.?4>?O5A+$,ZXX5-'5MJ0'\50MJX'\5KD=SN[ MUPMKJ/(RU;=MJ"D#FME6,98>QTPES2YS69#=!N]78WW5JJESFE"Q8%+NIF:B MDE"CK0ZAG:Y*TF*KO< =ZIS7JCO6;/J"\\UFZUCHIT;FI)> =ZJOJ07^*L&? M4A_>K-FU#/1JS^L.YT_5T=6VL ?Q4S^V!_>KBGOFSUJ/[>W]ZK]N-85'=KJX M/\56XM0#=Z\[34#G[U:UIJ73+5A*N-X5']J]!>ACUI MQK&4L/8W5;-3*:H03!AUJZC9K:%0Y)QL34M-%+79"5S$6BBBM!!1110 4444 M %%%% "4TTXTTFL*C&BAJ'^K-7B&>I@MSFKH\FH( M^34ET:\FHSZ"D6,8%,8T[=D5&U3 W>P1#]X*ZK21]VN6A/[P5U>DC. MVO1HL\ZNSK['H*V%^[619#@5K)]VO7HO0^?Q'Q#LTO:DQ2$\5T2V.%4NV?54$K";- MY6NRC$\ZO-'5:.F-M=3"<**P=)BX%=)''\M>M13/!Q$E*K3-@&N>K+0<%J?FK0L^6%9H^]6G9_>%8PW-ZKT.ST8?=KK(?NBN5T8?=KK(A\HKU M:"T/&KO4F6I14:T\=*[5H#6LQXK(ONAK*J]#:A\1QVLMPU<;,W[ MXUU^M=&KC)3^_->'B'J?04%H6XSQ2$\TD?W:BD?#5SQW.Y7-2UY(KHM/CSBN M8L7R176:9SMKLI0N<^(E:)OVML"HXJ^MJ,=*;:#Y!6@HXKOC2T/GJM5W*)LQ MZ4"T [5>-)2=,Q]I(Q+VWPIXKE-1CQFNUOQ\IKC]4[UQ5XV/7P,VSD;PX,UYM1'O4]B[$M3$<5#"*8]+FF-S7 M130/8T])7=(/K7>Z=:AHAQ7"Z,/WH^M>CZ9_J17KX6!X6/FT]!XM!Z4X6@]* MNA*J3IQ45*2L73JNYS=]" AKC=2XU)9#(%:(%>I"&AX56J^8H"R [4/:C M'2M'%,=T]*V88< <4Z=,52L0Q6H4=*M+'@5,$P*,5T^SL?:H?G:N:K!'?AIF)(WS58MN6% M496_>5>LAEA7*HZGIJ6AU^C1;MM=;%: H.*YS1$QMKLH1^[%>E1@K'E8FJU( MI_8QZ4HLQZ5?Q29%;N!R.I)E(VH Z5GW=L,'BMWJ*S;S@&N>K#0UHS?,-AB*Z[5GP&KBKY_P!X:\V:U/:I/0@C;,H^M=EH:Y"UQ$+?OA]:[K0! MD+5P,ZTM#LK5?E%76(5:J0':HIMS<;5ZUTIV1Y4DY2(;ZYV(>:X[4M4*,<-6 MGJ-[D$9KC]0417-[5GH*BK$[71/ M>HS<'UJ/RS2&,U:FV)TTB3SSZT?:#ZU"5HVFKYB.5(F^T'UIRW/O55E(J/=B MINPL:GVPA>M0'42'ZUGR3';5!ISYG7O6U-LRDD=_I-^6QS7:Z=-O"\UYCHLN M2O->AZ2^0M=])ZG!7CH=7%R@J.Y;"&GP?ZL5#>G$1KL;T//6YRVJ793=S7+W M>IE2?FK3UR;!;FN)O;@Y/-<%>1ZN'C=&LNIEF^]4IN-Z]:YB"X.[K6K#-D5X MM>3N>Q1@BQ(NXU'MQ4R\B@K7%?4]"*5B"C.*F\O-(T=4I"DD,64J:L)>E>]5 M67%1-D5O%G/4@F:@U,C^*@ZL1_%6$\A%1>:3WKHAG:5.70;62'2'%1(_ M-2N,U&J8-::Y*E0]*C0T-*XU4DGYJSIK\GO5%I"QZU$^2*Y)5+G?3I M6))=0;/6H#?L>]5W0DT^.V+=JSN=-DA6OF'>FC4&SU-2M8DCI4?V$@]* T)% MOF]:D%XWK40M".U/%J:3=A-$Z7S#O5N+42.]931%:%R*%,S<+G56>IDD?-72 MV-[NQS7GEM,4/6MNTU'9CFNB%0Y*M(]'M;@$#FM%'!K@[35QD#=726%]YN.: M]&E4/*JT[,W:,U&KY%.W5U<\&N. MU\_*U<565CLH(Y"[U(K*1FH!J9]:H7V?.-5T)S7F5)GKTHW1N#4&/>FM>DGK M5*)"12NI%91J:FLJ5T=+H]T2Z\UVMM:B=4TA1L276H'GFLUK\YZU4N)R>]4P MY)K!R9U1@:GVTGO1]H)/6J2@U*J\U+D:\B+0F-*;@K21QY%-DBXJXU+&;IDT M=\5/6M.TU,[@-U<\5(-30.5:M55,94KGH5A?;LZF0Q&ZLJ M;4R0?FK(O;_,AYJD;DMWKG=0[Z=*Q?N-2.>M0QWA<]:SG)8T^($&ES&Z@:;2 MY%5WF(H#9%-,>:3F7R#/M!!ZU/%?LO>H#":00&L74*]GPD/^M%==H_\-9B$=A9]!6JGW:RK/H*U1]V MO9H['@5_B'9IC=*,T'I6S9@D5)_NFN0UMN&KK;C[IKC-<;AJ\_$;'HX3XCDI MF_>'ZTPMQ44-3Z6C.R R -5J"88K*D+ T)*PJX4PG5-F60, M.*S+D$YJ>)F>I7@++TJ_9:G).L8\",9J['1[9CMXK%M;(F8<5W6BV6%7BNJE M3//K5C:TR':!Q6\B\53M80@%7ATKTJ:LCQZLKL0BH^]2FFXJILA,:>E4+J3: M#5]SA:P=1FVYKEJO0VHJ\C!UF7(;FN)NN9#73:C-NSS7-3\N:\JH]3VJ,;(K MH/FK4LU^9:SD'S5KV2_,M52C=E5-CL-%7[M=9&/D%AKFJ['10^(XS6NC5QI&&A\W4E=D;"DJ0BF,*F M4"4S-O\ [IKCM4[UU]^?E-Q@=#D+W[YJJG6K-[]\U#$,UY50] M^F]"U!5EC\M0(,5(3Q7'(U:(FZTE.-(11%&;0PFD')I&H7K7721$Y61N:./W MB_6O0],'[H5Y_HP_>+]:]%TU?W0KV<*M#Y['RU-!1Q3\4@%.KTXH\EL0U5N! MQ5HU5N.AI5%H53W./66I[V%,Z)2:)D.* ML6RYI;E %KAZG>]B"Q'[T?6NVTE3@5QU@/WP^M=UI"#:*[J"//Q.AU%@/E%: M54+,8 J_7K0V/#J;B4AI33:;1E $]*O8II6L)0-8SL5XH0.U657% M %*2!6L(V0.5Q:::89!GK2&5<=:ML5F.S1NXJL\Z^M-$X]:QE)&G(S/U<_(U M>?:K]]J[G5I04-<)J1RYKDJ2.W#P9STH_>5JZ/B7[PI%1D'-3XI-M=-CF4B,#BLN_Z& MM F0UV6JG[U5/<]V"T*=O$3*/K M7>:"F%6N7M( 7%=GI"!5%7$YZ^QT(;"UEZC/M4\U>=L+6!J\V$:J:AO+@F8C-+$=PKBK2/5H4QZ@"E.*8YQ46\FN92NSM<=";BG;, MU$F35Z"(L>E=$3GEH5A:EN@J1;)O2MZUL=P'%:*::/2MXJYR3G8X][!CVJJ^ MG/Z5W_\ 98/\-(='4_PU?(9>VL><2Z?)CI6<]BXDZ&O4)M&7;]VL>XT!E(S7H.D @+7/6=AY9'%=3IL6W;792.6L[HZ2#_ %8J&]_U35-% MQ&*BN1N0BNF6QYZW//M=B9BV*XF\MGR:]/U*TW[N*YB[TW)/%<-5'JX>5CBH MXHP*16DVG[3TJ,P;.U>1B$>U0=QT9XI^X5 3MHWUP=3N6Q9#"AG&*IF0B MF^::N*)98.#3&C)%$66-:$5N6'2NJG SDTC"F@8FH1;M73&QSVIAT_VKNIT] M#DJ31SWD-Z5I:9$1,*N&Q/I5NQM"L@XKLA3//K31V&BC$:UT$=8>F(545NQ= M*Z$CRJI+BHY"%%2]JH7LFQ30W9&,5=E>[NPBGFN7U+41AANJ35+XJ#S7&W]^ MQ3S5A29>M2B$"N:E8=3=:%!;0L>E:5M8$XXK2MK'<1Q6U:Z>..*VA&YSU:J1@_V:2/NTATP M_P!VNR33@1TJ0Z:N.E;^Q.-XJS.%.FD?PU&UE@=*[>730!TK,N+(#/%8U*=C M:GB%(XR>V([52:$@UU5Q:=>*R;BWVYXKD>AV1=T9/(IRRLIZT]TP:B88JHR) ME"YF03!E%6@359[="(0)@42QYZ5*!MJ55#5SJ6IV[ AQFLM\1C-5)KL],UO&9A.G<6\NBS'!JI\STPDN]:-K;%L<5:NS/ M1&6]L[4B6;@]*ZF+3=PZ5.=+ 'W:TY=!#6]+9;>U4)8"O:LW M%EJHB&,@4]@&JL[%34\!W=:AFB=R&2+VJ':5-:KQC;5*1,&LW*Q7($$I5AS7 M16%YM YKF/NFK45R4[U2JV,IT;G4S7WR]:P-2N2P/-0M>$]ZJS.9*U4[D*FH MHQ[@LTM/BA=JMK:EWZ5KVFGYQQ6JU(E9&5'9L>U/-JR]JZF'31CI4=UI^T'B MK:T)4T:\^C?;**ZG29S\O-=E& M1Y]>GH>AVDNX"M)>E8&FR;@*WT^[7L47H>#75F/%+1176CG"BBBF 4444 %% M%% "&HGZ5*:B?I6%1E1W,?4_]6:X+56^5-GO0V)STJ%Q4W:HG/%*+*EHAD7^M%=?HW(6N/B_UHKLM&'"U MV46>9B7H=?9C@5IC[M9MIT%::]*]BB]#P*VXF*4CBG4C=*W9A.]75TXLG2I;:'=-T[UTD%GNBZ5PJ%V M>HL19'%RZ8<]*C&FG/2NUDT[)^[3!IO^S73"D1/$G-0:>1VK1CT[6HXJQ;VJ@=*O)&%[5M&FD<52JV"+ M@5)FBFFM-CGW#=2$TVF2/@5$I%)$<\N%-:X[5KKKS7#5F M>AAJ6MS*NY\D\UE2-DU)++N8U%MK@EJSV84[($^]6K9G#+68@YK2M!\XKIPZ MU,*ZLCM]&.=M=7']P5R>B#A:ZQ/N"O7I0/!K_$.S2TW%.[5NT8,C<\5CWS<& MM:3H:QK[H:XZ^QU8=:G'ZR^ U:\.ON?18;8THY/DJ MI-)\U21@[*KRJ=U94EJ=OAUJ>9BG[IU M-J/W8JS4%M]P5/7K16A\W/XA*8PXJ2FGI2DA(QM2.U37$ZI+R:[35^$-FQ43'+TZ(5Y%9'T%+8L+3NU- Q3J\Z;U.D2EV\4 4_\ MAIQ9E(IRG!HB.33;@\TMMRPKMI&,]CI=%7YUKT331^Z%GY36538UI+WCFM5D^4UP6J2?O#]: M[35B=K5P6IM^\/UKQJ[U/I,+!6'VLE/N7^6JMIDU+<@[:XNIVN(MB_[[\:[G M2).!7!6(/G?C7<:0IP*[<.SS<4M#L[)L@5H5F6/"BM*O5@]#P*BU TVG4AJC M.PW-+FFFFDX%0V781Y,55FN<=ZCN9]N>:Q+R_"YYI*9T4Z5R]/J 3O69-K>T MXW5B7FI@Y :L2>Z9FX-8U:MCOIX9,['^V=W\52+JN>]<0ETP[FK4=V?6N">( M9U1PB.AOK[>IYKF+Q]S&IY+@D=:H3/FLG5;-8T%'8J8S)6UIRI4X:'7Z2,8KJ83\@KF--[5TD/W17JX>9X.*C[Q9HI!TI:[F]#B&MTK MU1\ UO/]VN>U8'!KEKO0Z<-\9QFJ2\M7-22?O:W=5R"UQ;++7::3]T5<'34TAHBP36$5J=$MBQ;6VXCB MMVST_)'%5+! 2.*ZNPA&!Q7=2A<\K$5'$6TL< <5I)9\=*M6\0 Z5;""O1A1 M5CQZF(=S.^S =J3R/:M%E%1[*MTD9JJV9[VP(Z50ET_<>E=!Y8I?)'I51HH? MMF*Q+JVV9XKO;Z$8/%O&=T#)2+%DU*Q IT3 FM(1 M%*=D6+2WW,.*Z.SL-RCBLS3U!<5V6G0 H.*]*A33/+Q.(<3/73?:G_V5G^&N MA2W'I4ZP+Z5ZE.BCRYXN1RYT?_9J2'2=K9VUU @7'2G"!?2MU32.66(;,ZVM M?+ XJV/EJQL %0N*B4;$<_-N(9.*Q]4FVH>:OR/M%<[K-QA&YKBJSL=%&%Y' M,:G<[G(S7/31EWS5N]N,S'FHX\-7!.9[M*&@D$.!3ICM%6% JM)6Q#;($BQVJ0QC'2I<8H)%=?LU8Y7-ME26($5F7%MD'BMMA MFJ\L8(/%<=6*-Z55IG)7=OC/%8%W%UKL[RWSGBN;OH",\5Y=6-CV:%6Z.8F3 M#&JQ&3BM"Y7!-4"?GKG3.V.J!+?)S6G:-Y)%00XQ39)=IKII2.>K [/2KK<5 M&:Z^U;,8KSC1+C+KS7H%D^8EKU*4CQL1'4T0>*8YXH!XI&Z5T-W1QI:E.X;@ MURFM/\K5U%R.#7(ZWP&KEJK0]'#I''7#_OC3TDXJK<-^^-/CR17DUD>W118+ MU(DN*KX-+@UR,[%L27$W%9^=[U-*":+2$M+6D$8U+)%RTLM[#BNDL=.Z<4FE MV60#BNHL[0*!Q7H4J=SRJ]:VQ4@T_ '%6389'2M>. #M4XA&.E=\*":/.EBG M/NUBWFGX!XKT":W4KTK$O[0;3Q6=7#I&U'$N3U/.;NWV$\57C;8:W= M4@VD\5@2 @UPU(61ZE*=RUYV1BF/R*KH3FK Y%<$SOAJ5W%1%L5:=.*IR*0: MS3U*:)$)-7H+?S"*IVR%B*Z+3K;)'%=E)7..M*P6NF9YQ6U;:=C'%:5E9C8. M*TXK8#M7HTJ5SRJN(,Z&RP.E-GT_<.E;J0@=J>80>U;NCHU1=T:WVC(J"XDR*@0FED!Q4Q-I(JKS+72:6.5KGHU_>5TFF#E:[:&YY M^(V.VTKH*Z./[HKG-+Z"NBC/RU[-'8^I[U-$S]*K.>:L-R*KN.:J(5'H.M_]8*['1^BUQD!_>BNTT7D+7;21 MY6(9UUIT%:2]*SK88 K00\5ZM+8\.MN24U^E+37Z5T=#!&=='@URNJ'.:ZFZ M'!KD=8?9FN.J=M%%.Q4&;\:["RA#1BN$T^Y_?]>]=SILV8Q6$;7-:M^A?%FI M[4OV%?2K$;YJ8&N^%K'%*4BF+-?2I$M@O:K.:3-7=$:CN;K:#S6%>ZA@'FL9U4=E&@VQNH7> W-WVXGFL:9O,-<%6=SVJ%*R*T9+-5L+\M11Q8-3.=JU@GJ=MK(:N-U: M5FN6%8ZR?O*W-/&XK7;0=F<.(V.QT9H< UMR'@UA:@>#7)7V.G#WYCC]6&=UJMN?D%61TKU(O0^>FM1U-/2EI#THD]"3"UC[C M5Y[JA_>&O0-:/R-7G>I-F4UYN(/7P)C2??J> <4QDR:L?0T63MQ35/ M-1-)FA7YKSIK4Z^A; XIK]*8K\4X\BB*L9-%&?K3[4M34HIJF@FO36QY-@8UGWA^4 MU>)S6??<*:QJO0VH_$O[[\:[[2$&P5PFGC]]^-=YI+?(*[*!YF+.H MM1@"KPJC:G(%7A7J4SY^KN.I*6DK61F-;I5:5P%-3RMA:Q+Z[V!N:YYRL:TX MW93U*ZV@\UQVIWY&[!J]JFH=>:Y:YF\UCS7.ZECU*-,KO>N\N,FK,9W+FJ2P M'=FKL8P,5R5:ESU*-,8Y(-/CD-*R9INS%<$I:G7RJQ*9,BHF-/49HD3"YI1E M+-ZGT%-:&AIWWEKN=('RK7#6/#K77BHMGM. Q56U)N/'2EIHIU4%QI%1L.*EIC=*RG:Q29D7W0UR M&KG -==J)PIKBM6DSN%>3B(W/9P;T./O7_?'ZU+;-Q4%V,RT^W.!7E5(GM0> MA-,^*2W4WJ-!I]1GBC=5LEDE1L.*=GBFN<+6$V-&3>OL!KC= M:N>&YKI-6GVAN:X;4Y][,,UY6(EJ>OA(W.;N)29ZNVQRM4WCW2YJ]"N%KSIR M/E6H,@X[UWFG6H$8XKEM,C *FNOLW M"H*[Z+1X6.;OH:$:A:F!JH):>)1ZUZ-*:1Y3BV3.:B#\TQI,]ZCW\UM*JA*# M+@/%,8#%0B4>M!E&.M6:))B1:]'TN7,:UZ5-GE8B!TD?(IY'%16YRM3'I71<\I[E M"Y'!KC=>X5J[&Z/!KCM=.5:L:CT._#7."G/^D&K<"_+5>9?WYJY /EKRJVI[ MU'8DVTA %*QP*J2S[37-8Z7HBQ *TU%>S1IZ'SM:HW(%6I *;TI0:[XQLCE>H,N15 M&[@!C-:':JMS_JS45$K%0;3."UF'!:N5F3!-=IK*Y+5QUW\I->1B$>]A7=%9 M1S5A*I*_S5:5L#->3-:GKT]$3E1MJC.OS5,T^.*9]\THP'.6A:T^'%XK$TFVR1Q79V%MA5XKTL/3N>3BJJ2-"T@ 3I5Y8A38$PM6 *]>E#0\&I- MMC0E(14E--:RCH9W*LRY%8M_%E36](,UF7R?NS7#6AH=="=F<)J5N,FL&6(* M:Z356P6KG9FR:\6M'4^DPTO=(D'-2.ORTQ#S3I&^6L8Z,ZV]"%!^\KH--ZK7 M.1O^]KI-,YVUWT3@Q#T.QTSH*Z*+[HK TQ>!701C"BO8HK0^=Q#]XE%+2"EK MM1R!1113 **** "BBB@!*B>IJBDK*HM"H[F+JG^K-<#JOWS7?ZG_ *LUP.J_ M?->)BCV\ KF&YYIT=12GFGP&O*DM3WX;$YZ5#(*L'I4+U4#.JB*$?OA]:[;0 MQPM<= /WH^M=IHHX6O0HGE8G8ZVW' J\@XJE;=!5]1Q7J4HGB57J+VIC]*DJ M.3I6TMC*.YGW)^4UQ&O-]ZNRNSP:XC7&^]7'59Z-"-S$L'/VC\:[S2Y/W8KS MZR<"?\:[;39P$'-IU3AH=3"_%6 U9D%PN.M3_ &E?6NR$M#S9PU+V[-!. M*J)J,UTH[UGS7P&>:PJ53:-&YL/?*.]4I M]17UK N-0(SS67-J+>M:YR\O*6F,>*F=ZA_KC M7H>M'Y&KSW4/]::\ZO(]C!(H&HV&:4GFGH,UY51GO4E9$.TTY4-6-@IRH,UQ M2>IU)Z$2J14F<"I2@ JM*<4$W&NPS3X3S5-WYJQ;$DBNFDC&H]#I])^\M=SI MX_=BN(T=3N6N]T]?W0KW,(CYW'O4O+TH-.%!KT^AY-]2.L_4/N&M$UFW_P!P MUA5>AM2^(XO5.IKE[L?,:ZO4^]?>->/5>I]'AWH0QTV<\4Z.H[@\5R/<[ M.A+IY_>_C7=:2/E6N"TT_OA]:]!T@?(M=E!'FXIG2VG05?'2J5KT%71TKU*1 MX-7<=32:4U&36DF9I$5R?W9KDM6E(W5U5TW[LUQNKORU<=;0Z\.M3D]1D?PUAE?WM=!I:XVUWT=3CJ,[;3.@KI( M1\HKG-+[5TT7W!7N8=:'S^*?O#^U,(YJ2D(KK.-,C/W:YW5CPU=#)PM]%Z%RS7]XM=OHHX6N,LA M\ZUVNC]%JJ9QUSI%7*UGZA;[D/%:L(R*+B$,M>C35T>>IVD>=ZC9X).*YZX& MQJ]"U2S&PG%<)JD+*YP.]8UH'KX>H5XY!4W7I5!-P-7H#GK7!)69W\]T.P5Y MJS:W!1QS3)-NVJ1DVOQ3C(QG#F1W6FZ@ %R:Z6UO X'->7VEZRL.:ZK3+XG& M37=2J6/*KT#M=^X4JCFJ%O&KB=3^\ MU>;7/9P>QRUR/WE.B7BEG'[RIX%^6O+J'KTV5Y!BK-@1N%07(Q4FGGYQ4TUJ M.IL=EIHX%=79?=%MAT>-BS5CZ5-4$?2IZ]2&QY$MQC"H\YA(61"%RU65&%J-14HZ5YTGJ>Q3V*LH.:M61VL,U$ZY-+%E31%ESV.HL[ ME5 K:AU%57K7$I<,M2F_<#K7739Y.(I\S.V_M91W%']KI_>K@7U&3/4TW^T9 M/4UV09PNB>@?VNGJ*3^UD]17 '49/4T@U&3/4UHVR'2/0?[57UI?[37'6N"7 M47]34HU!_4US3=A^S.MFU$'O63=7@.>:QVOF/>JTMRQKFDKG915B>YF#$UG. MPW4CR,349S4*)Z,)Z$^X;:SKHY-623BJTB%CTKHIQU,ZL]"[I'#BO0M)D^1: MX'3(R&'%=OI.<+7;!6/-K2NCLK4_(*G8\55L_P#5BIW/%;O8\EKWBA='@UQ^ MM]&KKKGH:Y'6_NM7+5V/2PQQB^Y7FU'J>Y1T1%+P M#6;<9)K2F-4G7)K-;FLI:%W18R9%SZUZ-ID0\M>*X;1H_G6O0M-7]V*[:*U/ M&Q*L 5[=%:'B3=V-(I!3Z,5T$7$[56N?N&K55[G_5FL:@XO M4X[5_P"*N,OQR:[+6.K5R%V,DUY&(9[>$9DHIWU:_@I@4;JD(^6O*EN>S'8J MOG=5FV&2*@8?-5NV'(K6"(J/0ZK1HP2M=I:1X1>*Y'15Y6NUME_=BO6PT=#Y M[&2U+*# I](*6O3@CS6%--.HJF"(6%9]^/W1K385F:A_JC7/5CH;TGJ<#K'W MFKG9#S71:S]YJYV3K7@UUJ?28;X1(Q2S#Y:6'K4DX^2N/J=KV,V/_7"NKT@9 MVURJ#]_^-==HX^[7?0.#$;':::.!6\GW:P].Z"MQ.@KVZ.Q\[7^(=2T45U(Y MPHHHI@%%%% !1110 5$]25&]95-BH[F-JG^K->?:LWSGZUZ#JG,9^E>?:LIW MGZUX^*1[> ,"0Y-/A.*9(,&G15Y,MSWX%K=Q4;4['%-:G'7I7ITV>+5W''I4,AXJ4FH9!Q M6SV(CN9=W]TUPNOM@-7>7:_*:X/Q#&2&KAK:'J8M<#G9GIX;UK2-4YW039UZZW_ M +5..MY'WJXM9V/>I?.;UINJ"PR.HDU?(^]5*74\]ZQ#,WK499C6$IF\:"1I MR7F[O5=Y<]ZJ@FG9S7.Y:G3"B@?YJ@,635@"G;:ELZHTK%=4Q5F/BFE:4<5# M9TJ.A+NXJ"8\4_.:BEZ41>IG.)53_6BNFTH_=KF8_P#6UTVE#E:[J1Y&+6AW M&EG@5T*?=KG=+' KH4^Z*]JB]#YRM\0^@TE%;W,2*0_*:YW4^]=#*/E-<[J? M0URUMCJP_P 1Q>I\%JYQF_>UT6I_Q5SCC][7DU=SZ"AL6T/R5 Y^>I4^[4;+ MEZQAN;S>AO:.,D5W.GIA5KB]%3D5W5B/E6O3H(\K$RT-B'[M35%$/EJ;M7I1 M6AXLMQA-1,>*D85$W2LICB8&M-\C5Y[?M^^-=]KA^1J\\OC^_->9B&>S@D0! MIL\5#)5Q5S.12DZUH M:>FXBJ+KDUJZ8,$5VTHG)5EH=7I4&-IKLK+A!7+:81A:ZJU'R5[6%6AX&-=V M70:0F@4AKT>AYG4::S=1X0UI5F:G]PUS5=C:E\1Q>IO\QKF+HY8UT6J?>-DM#P:FXC5$W%3&H'JYDQ*=V_[LUQFKORU M=;>_ZLUQ6KORU>?69Z.&CJ<[U1B6EZ4;J!TII M'-A$=UIK'%.6FN,UDY%L5&R:=+]RF1CFI)?N5<'J831G$_O:Z+2N=M]#8MVCX=:[71GR%KA;;_ %@KM-%/"TX(YJZT.SMSP*LLN5JG;'@5? XK MTZ*T/'J:,RKVVWH>*Y+4M*W$G%=]*F169=6H8'BE6AH=-"M8\TN-/\LGBJ#G MRJ[B^L,YXKE=0L6&>*\Z<#UJ55,RFN\\9IH;<:A>W9'-.C.#7/:QV1LT78>" M*V+2[\K'-8\1R*D+$5K&5C.=),ZZVU;&/FK;LM2WDM;6G7NUAS77 M2JL\ZOAU8]+MI=ZYJR#7.:?J *@9K:AF#BO0IU#QJD&F6J:QQ2@TUJZHRN96 M&YYIXJ,#FI157%86HWZ5)43GBLIO0J)A:L<*U<-J3_,:[;5S\K5PNHCYS7F5 MV>QA+F'+R]6(3\M5Y/OU9A'RUYD]SUXZ(KW5/T\?.*CNN*ETXYD%.GN95)'9 MZ6.!7660^45RVEKP*ZRS'RBO7H(\?$R+R5*#40J05Z<%H>=(?24M)0R!C]*S MKIL UHOTK+O!P:XZ^QT45J&NKUKC=7).,9I/))[5OMI M39Z4Y-*;^[67LC:-5'/_ &4^E--L?2NG_LLXZ4PZ6?[M"I&T:Z.:^S'TI199 M/2ND&EG^[4R:8?[M;0I6%.NFC)L;'!'%=3IUOMQQ4=M8;<<5M6MOMQQ75&!Q M5*FAH6JX2I7'%$2X6GL.*;B<5]3+NA@&N0UO[K5V-V.#7&ZWT:N&L>GACBY? M]>:M1O\ +5*8_OS5F,?+7EU#VJ;T$E;-1=Z?)UI$7)J8;E3>AN:,/G6O0-.' M[L5PFC)AEKOM/'[L5Z5!'BXMFM%TJ:HH^E2U[-+8\>6XA-)FE-- KH <>E5K MD_NS5@]*JW/^K-CNI:8U1+8:W,;4A\AKA-57YC7?: MD/W9K@M6^\:\?&(]G 2.:G&&I8>M$_6FQ'%>1):GT,'H6STJ,TN[BFT1W(J; M$UN/W@KL=''"UQ]M_K!79Z,.%KT:)X^(.IMN@JZ.E4X. *MKTKTJ9X]3<7O2 M-]VG8J-S@5OT,T9]WT-<7KB AJ[*Z;@UQFM-PU>=B&>IA4<@\8$I^M3(,"HF M.93]:LQC(KR9/4]R$+HC8'%5I :T?+S2&VSVI>TL/V9GQJ:GQQ4Y@VTFVFIW M$X%?!S4JKQ4GE4N,5$IEQB0L,4+3FJ,G%9.1O&),*=4 >I U+G-T/J-J4M3# MS1S7+2%4TDO2@<4V0\5<61-:%>,?O175:2/NUS$0_>"NGTO@K7?1U/&Q:.UT MT<"MY/NU@::>!6ZI^45[%'8^;K+WB2BF9IV>*W,;#)/NFN:U4]:Z&5L*:YK5 M6ZUSUMCIH+4X_4>2U8+C]Y6WJ!Y:L1O]97D5=&?04-B9.E 4;J%^[29^<5G3 MW-JFQTVCKRM=K9#Y5KB]%Y*UV]F/D%>I0/&Q+-6+[M25%&>*DS7HIZ'DRW$( MJ%^E3&HI.AK"HQQ.8UT_(WTKSN];]^:]"U\_(U>;WK?Z0?K7E8@]S [$D72I M<5!">*L"O*JL]RF0R"HUSFK13-((N:YSHOH,[5$]62N!4$@K:!SSD5\M:NG+N(KOI1N<%61U>E$_+7868_=BN5TR+ 6NKM.$KV<.K(\/%N[+8I M"*6BNSHAO1^(XG5,;C7+W7WC71:H_S&N=N.6KQ MJNY])AMAL5+,.*:AQ1(Q9TW_6CZUZ!I/W!7 :;_K1]:[W26^05VT$ M>7BT=-;]*N+5*VZ"KHKUZ6QX-3<&J&3I4QJ"7@5=17)CN9M\?W9K@M:?YFKN M-0?]VU;7/5PJU,4G)IR"H-W-31G->15W/9I(L#I1@4=J86YKCD=T M4/HI :0G%9,L>HHE^[34;)I\OW:N&YE-%#'[VNBTK^&N;)_>UT>D_P ->MAS MSZZT.VTSH*Z.,?**YW3.@KHH_N"OH,.]#YS%?$24AZ4M(:Z7L]#8DMC\XK MLM&/"UQ$#XD%=EHK9"TH+4QK+0[:T/ K27I679G@5JI]VO4H+0\6ON-(S4;Q M BK&*3%:SCD7NF[L\5S=]IFS)Q7'.BT>O1KIF%$<#FI"%)@,U MVNC7V0O-=E*9X^(HG>(X(I]9MK/O YK24Y%>A3D>5.-F+BEHHKIN0(:@D/%2 M,:A<\5C-EQ1A:KT:N*U'[QKM-5^ZU<3J!^FD07M+I9_>CZU%=MFI-,_P!8/K6E'DM\J MUUUF/EKV<.CQL2RV*>*;3EKT8[' Q]%%%#(&/TK-NA\IK2?I6;=?=-<5?8WH M[G$:[P&KD#_K3]:Z_7>C5Q__ "U/UKQ:R/>PVQ; ^6H).#5A?NU!**XK79Z< M=ABMS6UIV&(KFWDVM6[H\FYEKII1,JSLCL+2W#**UX;!2.E4]/&56N@@3Y:] M2C \#%5'E!L4]*NYHS6O*@NR@=/3TI M/[.3TK0S3A6;IIBYFC,.G)Z4#3D]*T\4F*RE3'SLS?L"^E--@GI6F13,4HTR ME-F?_9Z^E.%BOI6@!3MM;1@@]HRBEHH[582$"IMM+BKY2')B 8%(W2GTU^E1 M*(EN95X>#7%:ZW#5V%^^ :XC6GR&KS*ZU/7PL=#CY#^_/UK0A'R5GN/WY^M: M$)^2O,JH]FFM"*4:=(,FG1#!J(+4*NQT&DK\RUV]A]P5Q6D_>6NWL1^ M[%>G0T/$Q3-2/I4HJ*/I4M>O3>AY4MPHI":3-;BL*>E5+K_5FK)-4[H_NS7+ M6V-(+4X[6#RU*R=1_P!6:XZ[T.J@ MM3AM7^\U8#CFMK5W^=JQ,Y->#7W/IL+'07BMCK;)< 5J+TK,L^@K3'2O;I;'SM;XAU+2 M4M=,68!1115 %%%% !1110 4QJ?36J9;#1E:E_JS7 ZLOS-7?ZC_ *LUPVJC MYC7DXI'K8'14/HZ6Q,.E**.U*.M1'<55%BV7]X*[71 MEX6N.M,>8*[;1APM>C0/%Q1TD(X%65%11#@5..E>I31XTWJ*1Q4,HXJ>HY1\ MIK9[$1>IB7C8!KC-9?.ZNNU$GFN+U7)S7EXD]G"*YS9_UI^M6XFXJHP^-5E9GO4UH7%<5()1BJ6XTA M*G IL@XK6.Y,Y:%>+_6"NETQ>5KFX_\ 6BNHTH?=KT<.>/BCK]-' K='W16+ MI_:MM/NBO9I;'SE?XA,4N>*6FFNA(P(9ONFN7U4XS74R_=-)BMS23I4M1I]VI*]!;'ERW$-0OT-3U"XXK.:")R^ MO#*-7F]_&1.37IVLIE&KS[4HOWA->9B4>W@G9&=&^VK*R9K/34B> MW3D:2M3\U422I?,XK%0U-7(=(V!5*27FI99.*SW)+UT0@A\1P.J#YS6#-UKHM3QO-<]<=: M\6L]3Z6ALB%:&%*E*UIV6T+>FK^\'UKO-*3Y!7#Z8/W@^M>@:4HV"O1PY MY.,D;ML, 5=%5H!Q5H=*]>FM#P*CU&FH)NE6#4$O2KFM AN8FHC]VU>?:T?G M:O0]1_U35YUK?WVKRZ[/7PNIBJ,FK,:XJ"$9-7 .*\:L]3VZ2'=JC(YI]+BN M1LZTQH'%(PJ3%)BLV4-08-/D/R4@ILAXK2"NR)%+&9:Z;2%^[7.KCS173Z2/ MNUZU \^OL=EIHX%;\?W16'IXX%;J?=%>]AUH?-8KXA])1172O(J[GO06@L/^M%=G MHG1:XRW_ -8*['1CPM*GN35CH=Q9'@5KQ_=K%L6X%;49^6O4H['A8A:DE% I M:ZK7.4::AD4&I33<4I[^"CH8\@^:GHO%-?[]6(A\M<#9Z:B9] MRM3Z8/W@IMVM3:6/W@^M;TMS"JM#MM)7A:Z^R'R"N5TK&U:ZNT/RBO8H2/!Q M:+>*4"E%+7H1V//N+1129ILD:_2LZZ'!K1;I5&X'RFN.LKF])ZG#ZXG#5R!3 M]Z?K7<:S'D-7(RQ;9#7D5D>[A7H(H^6HY1Q4H(%,?D5Q):GJ1>ADSJ=U;.BG M#"LV9/FK1TSY6%=5-&-75'H6F/\ (M=);_KAW<^?QD; M,MYI#S29IPKOBSS]A,48I^*,507&8IXHQ2TQ-B4AIU,:H:!"$TF*3O3Q22*V M% IU(*6K2)$HHI*9+8M-?[IIU,?[IK.12,+4>AKB=7_BKM]1Z&N)U?\ BKS: MZ/=P?PG)N/WQJ[$/EJHP_?&KL?W*\R9[%-:#';!J2'DU6F;YJL6G)%1".I-5 M:'2Z0OS+7;V(_=BN-TD!BMS13I4E1I4@KU::T/,EN(13<4^ MFFMK@AC53NO]6:N-5.Z_U9KEK/0UI[G':N>6KD[DY)KJ-9/+5RLQY->+7W/= MPNQ54?-4K?=IJ]:>P^6O/EN>G%Z%+'[VNCTG^&N?Q^\'UKHM*'2NFD856=KI MO05T47W!7.Z;T%=%$?D%>SAUH?.XOXB0]*B(YJ6FUVW.($%*>E**#3;T @DZ M5D:B?W9K7FZ5BZB?D-<5?8Z\.KLX/6!\[5B]#6[JWWFK"?K7B57=GU.&^$=F MFL*133STK%(ZI+0?:C]Z*[/1UX6N.M!^]%=QHR_*M=M!:GDXO1'36@X%:(Z5 M2MAP*O"O9H['SE9W8M%%%=*T,A:***L04444 %%%% !333J2HD!F:B/W9KA= M5^\:[W4!F,UPVJI\QKS,4>M@'JE0/"QC.F3@5*#4:_=J0"O2@> M0Q]1R_=-2=JBE^X:UEL2MS#OQG-<;JJ]:[#4'QFN-U23.:\S$'LX1G.LO[PU M(J5&S?.:E1J\:JCW:0;:394O6C%<,F[G2ABQT_RJ*;TI[/49 M.33;(NQVZD+8H"TK)FI3U+3(_,I=](8S2;:H:9)OIP.:A J1>*N(^8DJ.0\5 M)G-1N.*UCN95)$,7^L%=-I9^[7-1?ZP5TVF#[M>C01Y>)9V.G=JVQ]VL33AP M*VP/EKV*6QX%;X@S2GI2 4[M71?0Q*\QPIKD=:;[U==./E-<=K7&ZN.J=6'W M.0N6^8U0<\U7-4F'->36W/H,/L)4D9^85'4D8^85G!ZFM38ZO1CRM=K:? M=%<7HHZ5VEJ/D%>E1/$Q.YI1GBI!44?2I17HQ/+D+3&&14E(15-"3,'58\J: MX/4X/G/%>DWT.]37*:AIY8DXKAKT[GHX6K8\_N(R&JODK727>FG)XK.?3CZ5 MY\Z)[%.L44D-2&4XJ;[$5[4AM2>U9*D;2K:%0R%CBI8H2[#BK$5B6;I6S9Z6 M21\M:QIG%4K#=/M>1Q78:9!MQQ5*STXKCBM^T@\O'%>A1A8\^M5NC4@7""K MZ5#&>*F'2O0@>;(****;8AC5C:I]PULM6+JOW#7)7>AO1^(X34V^-CC>AJP*KPCBK%>O#8\&>X5#-TJ>H)NE7+84=S#U(_NVKSO6_OM M7H6I_P"K:O.]:/SM7E5T>UA$94/6K@Z53M^35X+Q7BUMSVZ>PE*#2&D%.&U!LLU8,P^:N@OD^=JQ9TYKRZFY]%3CH00G M$@KK-(?I7)H,2"NCTN3&*SB[,52.AWEC)P*W(7RHKF+"7(%;T#_**]"C,\/$ MPU-)33JA1N*D!KOC(\]H,48IU%:7$,855G'RFK9JO./EK.>QI!ZF#?+\IKC] M5CR3787S8!KC]4D&37EU['O80YF9=K&FQ-\U32#>QQ2) 0_,OXUI2W,:R5CL]!ESMKNK1OE%>>Z!QMKOK(_*M>K0/"Q,3 M60\4^F1_=J2N^VAY3W&GI56;H:MGI52?H:QJ*Q=/E+4PJQT.UTR3 %=59R?**XS36X%=592?**]:A,\+%P-E6J0&JL;U,&KU( M2T/*E$D)IN>:0M3<\T2D)(>>E5)QD&K.>*BD&16%1W1<-&/B: M=SLHVS4PK+M+D,!S6@CYKOA4N>1.+3)J*0&EK=2T,K!124FZDI!8=2&DS1FD MY )BC-!-1LV*%(JQ-FD)JJUP >M.27=6BD'*6 :=3%I].Y+04U_NFG5'(?E- M1)C6YS^IM@&N*U1L[J[#56^]7$ZDW+5YN(9]#@H^Z8#?ZVK*GY:JLJUV5G_JQ7':2.5KLK/\ MU8KU**/GL5N7D-2@U$HJ4"O1@>=(":833C3<5HV)#6JG=?ZLU<:J=W_JS7)6 M-8;G$ZT>6KDYVY-=3K9P6KDYN2:\:M>Y[>&>@V,Y-6&'R56B'S5;/W*Y+:GI M)Z%+_EI^-=%I(^[7/[?WHKI-)'W:Z*2,*KT.PT_@"MZ$_**PK <"MV(?**]? M#['@XK4\5C:C_JS6S*.*Q]1'[LU MP5MCLP^YP>K-\[5ADY-;>KK\[5B'@UXU5:GU&%?NB=*<&IO6E K)+4ZY[%RS M'[T5W&CCY5KB++_6"NXTE+']ZLH[FT]C3LE_>"NY MT885:XJP7YQ7;Z0.%KT*#/!QAT:=!4@%1)TJ6O3@SQV+4[ M1E<5:4FFGBF[JX)([DM!^::S4TFD'-"(DAI)S3UI=E'2AB425:DP*A4TI?%2 M@Y21@*A(I/,S1UJQ,,4G2G4AIDL532R$;:9G%1R/Q6]-&$V+%S**ZK24)VUR M5LT"KXZ5Z]/8\*J[L,4&BBM6S M(AF'R&N,UW^*NTE^X:XK7_XJY*LM#HH/4XR?[YJLPJ>4_O#41KRJKNSW\/+0 MAJ2(_,*8U,#X:LX+4Z9;'8Z,PXKM+1@4%>?:/-@CFNVL)LJO->C1D>1B8=3= MCZ5**AA.5%3=J]*&IX\MP+4NQ(]T#50N;16!XK3[4QTR*RG3N M7"=F"3\M4'TT?W:[&2T#=JA-B/2N>5 [H8FR.)ET[_9JO\ V><_=KN' MTT'^&H_[+&?NUBZ!H\6CEK;3OF^[6_96"@#BK\>G!3TJ['!L'2G&C8PG6N1P MVJJ.E3^6!TI>E+D&MXV1SML%ZU87I42@5**WBS.3%I,T&FDTVQ(1JQM5_P!6 M?I6OFL?5SB,_2N6MJC:CI(X'5#^\-8FLIAFO&JZ,^DP[T1$!3QB MF-Q0K9-CAD>+CC M77D>YA(V,FU'-:':J<0VFK.[BO'K;GLP&FDR*&-0[N:Y4KFK=B?-!HCYIS#% M/E%S#0*20<4Y>M+*/EK2"$Y:%-1^]'UKJ-(7.VN64_OA]:[+0X]P6O1H(\_$ M5+(ZO3P0!6XGW167:Q[0*TD/%>S1E9'SN(?-(EI#TI!2GI72I',5ICP:YO53 MP:Z2;H:Y76&P#7'79WX7XCE+W&XUBS@9K1O9?G:LMFW-7EU)'T=+8AV_-6M9 M/MQ5)(\U.K;*QY@G'0ZVPN@,IM'S5YW'?&/O5V'5R.-U==&I9'F5J/ M,ST:.]3^]5E+M/6O/XM8/]ZKL6K$_P 5=D:Z1QRPC9VXN5/>E^T+ZUR<>J9_ MBJ4ZE_M57UE$/!LZ8W*>M5;B[3:>:YR75<#[U9UQJYQ]ZE/$IH4,*[FEJ%TI M#=M=W:1X05Z]")X6 M*FC0C^Z*?FF+P*3=S7H+8\E[DAZ54G'!JR#Q4$PX-955H73W.3UH?*U<)>#] MZ:] UE?E:N%O4_>FO"Q*U/=PM;%MJ1 '-=].K8\[$4.8 M]!BNUQUJ;[8H[UQ<6J''WJ5]6(_BKTZ=?0\N>$=SLA>)_>J1;E6[UPR:P2?O M5HV>I%V'-;>TNK;J<1Q52RDWJ*N'I4LYGHS/NDR#7)ZQ"2&XKLYEW M"L/4;7>#Q7'5B=V'G8\PNX6$QXIL7RXS717]AAB<5@W">6:Y)1/;HSNBW&ZX MJE>MP<5%]H*T9\VIV.K(.]5I=0CQ]ZN1N=8*C[U8TFOMOQNJO M:D_5VCN)+X%N#6A93;L*=4,;?**EK1 MS.1H4FH93\IJ6H9ON&IE,J.YS.K/@-7$ZDV2U=;K3XW5Q=VVYC7FUI'T>"?N MF3SYM:$>-E5"N&S4@? Q7!)GJ*5D,F&6JW9#D55/S&KEL,$55/5G-6E='5Z5 M_#7868^05QND'E:[6S'[L5Z]!'S^)>I=04^FK3J[T]#SF%--!--S0V-(:U4[ MO_5-5MJH7C?NS7-59M!:G#ZX?F:N6?[U=1K7+-7+O]XUY5579[&'T0L?6IB? MEJNIYI7?"US8/K71Z5_#7)"7]Z/K75Z*=VVMZ<3&I([2P' K=B^Z M*Q;$<"ME/NUZ-(\/$ZR):7%,!IXKMBSD:#%+115,17FZ5B:BPV&MBZ;"FN:U M.;"FN&N=N&5VA;L_]:*[O1ONK7!V1_>BN\T7[JUV44>-C'='40=!5D=*K0]!5D=*]2GL M>'/<6EI*6MXF8M%%%:H04444 %%%% !24M)42 JW0RAKEM2AX)Q763#(K#U" M,%&KCK*YW8:5F>>ZBNUC68O6MK5TPS5C)UKR*RL?08>5Q'X%)"2*[/3$P!7+:6H^6NNL, "NV@]3P\8C93I4F>*A1N*DSQ7I1 M9XS6HN:;)]VDSS39&^2KY@2U,;4#PU<1K'.ZNSU \-7%ZL.M<=5GK89:'-+_ M *W\:T8S\M9^/WA^M7(SQ7EUT>S1',,TW;3\BEXKSY'H1>A$4H"XJ;%-.*E# M:$S3#0>M**=AI *#S12BHMJ-Q&!:>!3^*2J1FT)333J;6B1DQ,9J.1.*F6A\ M$5M PFB&T7]^/K7H&A#Y%KAK5/WPKNM$X5:]##[GDXM:'51=!5@&JD3<594U MZM-GBS6I)32:4GBHR:UEL0D)+]PUQ>OC[U=C*XV&N/UPYW5Q5GH=-"/O'$RC MYS49J:XX]1AH(XXJ CYJM[9V MC-<#$Y0UT&EW1#+S752J:G%B*>AZ1:R[D'-7 JUQ= 9YK,ENN>#7.YZG7&E=' M01788]:OQMN%$[F%6GREJF,*=FDJVS%#,5C:Q_JS]*VC M6)J_^K/TKEJRT-Z6LCSO4_\ 6FLPFM74Q^]-9#YKRJNK/H\.M!C:;4T M0YKG3LSLOH:^EK\X^M=WIAP@KB--'S"NUT[[@KT,.SR,:C=B/%2GFJ\/2K K MU(2/#EN %07'W:L57GZ4YRT"'Q'.:D/E-<1JAPQKNM2^X:X/5@=YKRZS/=PK M,Y#S4PZ56BSFK(Z5Y=7<]: $9%,\OFI0*D %8)&DAJ#%#TXD5&QJC.XBG!HD M;Y:;GFD;)%:00297C7,X^M=OH7"K7'0I^]%=EHHP%KNHO4\_%1T.PMSP*O+T MK/MCP*OJ>*].$M#P*JU)!0>E)FD+<5MSF-B*;[IKE-9&0U=3*WRFN8U;H:Y* M\]#NPB]XX6^7#M67GYZV=0'S-6-_RTKRIR/IZ4-#0A7*T2+3K0U!>[.]!U'_: MK"FG/8U!]H;/6CF&X*QOR7V1UJG)<%N]9PF8]ZD5B:3DS'E2)3EC4B'%-4C% M(S5FWWBNNMQA169:VX0#BM6+@5[-%6/ KRNRQVJ,]:D[ M4S'-=:.)CUZ4R0<&I%Z4UQQ45%H..YS>KIE6KA=0CPYKT/4HMP-<7JEL*Y M)T['JT*YPLL)4TZ'Y36O=6+ GBL\VS*>E?ZIJY:R.BF<)K;X9JYHMEC70ZZ# MN:N:&0W-<$XGHTIDH%-D^[3@12,,BL''4ZE4*:IF4?6NNT1#ZUU6 MD<;:UA$F4KH[6QZ"MA!\M8U@>!6W']VN^E'0\?$/W@QS3Q1BE%=44&KJKP_*:Y/5#P:X<0CMPSL<5J/^L-5X),58U'[YK/4FO-G$ M]RC4T+LDN154GF@DTVIC VE,NV)_>BN_T095:X"P'[X5Z%H?W5KJI1/+Q4M# MI81P*LBH(CP*L#I7I4UH>-)ZA1116J)%HHHJT(****8!1110 E-)IU,:LI#1 M')TK+OES&:TF.:J7:9C-<]17.BF[,\^UF/YFKG6^4UUFLQ\M7+3#!->57B>Y MAI:%=CFI+5?WE1=ZLVXPU<6S/2W1TVFG %=-9RXQS7'VDVW'-;-O>;<M1R2C;6#_ &J" M?O5)]N#+UJW514:+)+Q@0:Y#51UK=NKO@\USFH3;\US3G<]"C!I&"1^\-3*< M"F,/G-/'2N*J[GHTKH-W-2*U1[>:>HK@FM3N@QY-,)IY%,(J4C5,***7%)EH M2CI2XQ28H0V*#3NU-QBC-!DQI- H(R:4"K1#$8XIH?)HDZ5"K8:M(,RE&YIV MBC>#77Z6VT+7%VLV&%='8W>T#FO0HR2/.Q%.Z.T@E&.M7%D&.MKTZJI3,XT)7-F><;3S7+ZL^ M[-6)-1#*>:Q+^[SGFO/KU#OH4&F85X<$U05\O5JX?>355$^>O-G,]>E39?B7 M*TR5*FAX6DD&:RYSKC HG@U=LIRC#FJTB41?*:TA4,*M*YV.GWW &:Z2TN\@ M]64D!KDX-3!_BK1AU 'O7="N> M94H,Z$,*7=64EZ".M2BZ&.M=D*R,'19>)%-+ 52-V/6HVN_>K]HAJDS1#BD> M0 =:RFO@.]5Y=2'K6,ZJ*5!W-&>X '6LFYO< \U2N=3&.M8=WJ>2?FKDG6.J MG1+]S?\ /6J8NMQZUCRWFX]:=#/SUKFE5U.V%+0ZBPD^85U5G(-@KA+.YVD< MUN0:F%7[U:TJQS8BBSK!(/6@R"N9_M@#^*D_MD?WJZO:JQP^PD=&T@K&U5P8 MS57^U@?XJS[_ % ,AYK.I3K(_O5Z4:B/%G1E:YF^GW,:\^K,]C#Q:**K@U**A5LFI,\5Y MLWJ>I3V)*-U,#4_;D4HFDAI:HV:GLM1E:9EU%3DU8V<5#&,&K.?EK2(V-A3] MZ*ZS2!@+7*1MB05T.G7 4#FNFG*QR8F-UH=C X %75D&.M MC!6.-RN/%.Q2**>*V1DP I".*=10R3.NH=P-<[J%CD'BNMD7-9UU;[@>*\[$ M4[G71J6/-M0L,$G%84\9C/2O1[W3MV?EKGKO1B2?EKS)TV>A3K')K(PI_G,* MUI-)*_PU =./I67LCT*=70H>>QHW$BKZZ:<]*G733CI5QIV-/:F*V:01%^U; MO]ED_P -6(=)/]VNF$#FJ5#,L;0[AQ77Z7;X(XJ*STO!'RUT5E8[,<5V4X'F MUJIJ6"X05<8XIEO'M6I66NQ1T/-D[L13FG%*[Z>UW=JR[BPSGBN*K1/2HXC0X M.>V*9XK.E=D-=K=:9G/RUC7&CG/W:X*E([X8A'--.U1-*S5MR:0V?NTP:2?[ MM9*F;^V1AG)H&16Z=)/]VD_LH_W:OD#VJ,8R-MJLY)-=&=)./NU$=(.?NU2@ M+VB,2+-78@36I%HY_NU>ATE5IC\IJT14,J9%)P*@]3DM6SS7(W2$L:[Z_LR^>*P)]+))^6N>=(]. MC5LCC9(CGI4#*PKK&T@D_=IG]A$_PURSHF\J]CE51B:U[&(Y'%:JZ"0?NU?M MM)*8^6KITCGG6N6M*BP5XKK[5<1BL2QM=A'%;\*X05W0B<-65V3"BBBMT+I:8U1(:*_>H[@9B M-3$5%-]PUSR-EN<9K$62U+M)KT#4H=P:N&U=-A->;71[&%>AE(]6DNL=ZR'D*FD$Y]::F93B;?VXCO44FHG M'WJQ9+@CO55KECWK55#DE2NS?34#O^]6E#?93K7')<'/6KL5V0.M#JW*C2-^ M>ZW=ZRYY-U1":0U760YKOA/0YY4$=!]O;;]ZHOMK9ZUE^:<4"0YJI5-#-4$;271(ZU4 MN9"W>HHY.* MIN:\HY\&HNE.!S0133U(G'0 Y'>I$N6!ZU :9G%=4:ECBG3N;-O>D8YK4@O_ M 'KDO.*U/%>$=ZZ853AG1U.WBU 8'-6AJ2X^]7#C4"!UI?[4;UKIA6L9?5[G M:-J(_O5$VI#^]7(?VDWK43ZDWK6OU@M88ZN74A_>JE+J&?XJYMM08]Z:+LMW MK&5:Y?U5R>M.$A:E,>ZN:54<:)5#-5N%S4+1XI5.*P=0ZHTK( MU(Y\#K4WVP@=:R?,XH,IK2%6QE4IW-![UO[U1_;V_O5GLYJ%Y"*Z85;G/[%& MY'?,?XJ)[DLO6L>&8YJR7RM5*9<:-BM,Q9Z%0FI-F6JW%",5RSD=<%8I[#32 MIJ^\8%1^6#7,Y:FZ((2RFM**Z*KUJF4VBHFD(K:G(QJ0N:37K>M1-?M_>K., MIJO)*:[(5#CG01M)?MG[U3B\8CK7/PS'-7DDXHG5,E229>EG++UK+N"6-6=V M13"@--34Q4XJ5(P*DV"N9G7!%15.:L+TI60"HF;%.++Y;BO3,4 MF[-**!M.UN, *8@5K&9$HZ&X][@=:@ M.H'^]6/-E1BQ^;I7 M3FT'I2"R&>E7[ 7UHQ(; ?W:N1V"_P!VM5+4#M4RP =J%0U,98BY0BLE'\-7 M$M5 Z586/%2!:U5(YYU&R)8@.U2A12XI:VC&QDW<810!3\4A%;Q0KBBEI@-/ MJ[":#-&:8329I#L/.#4;H".E.S2UC40;%*6W5NU49K%3_#6R5S431YKD=&[- MH5+'+7.G#G"U0.G<_=KL7M0W:H_L(]*GZN=<<59'*+IO^S4RZ>/[M=+]A'I3 MOL8':CZN5];.=73Q_=JS%8K_ ':US:@=JEC@'I6L:1$L1=%2"S48XK2BA51T MIR18J4# K>,+'%4G<0 "EHI,UND8.049I,TA-58GFU'YHQ48;FI!TJ6C1#&0 M&J\D*GM5HTS&:RG"YI%M&=):*>U4I;!3_#6Z4S4;0@UR3HW-XUFCF9-.7/W: MC_LX?W:Z9K8'M3?LH]*R>'.A8K0YIM.']VFC3AG[M=-]D'I2?9!Z4*B/ZT<] M_9PQ]VHSIHS]VNG^RCTIOV0>E'L0^M&%%IR_W:MK8+_=K56V [5((?:M(T3. M6(N90LE]*F2R4'I6CY-*(\5LJ1DZMR**W5>U650"E5:=6L86.>4@IMFI/2K*6*8^[4ZI MS5A!Q64Z8YS*?V%/[M--HHZ"M'%-*YHC3L9J95BA"GI5M!@4@3%/%:I"E*XM M)113W("FDT$TW-!20F*1D!%2 4N*AJX[F9/;ACTJ-+)>XK3:/--V8K)P-%/2 MQ5%DG]V@V:8^[5P4[%3[,GF9FFR3/W:>ELJ]JM$48J5'4KF$C0"K Z5$.*7- M=$=$0]23(I)E37"Z[']ZO-Q$3UL+(XR%<2_C6JI_ M=U0"XE/UJXI^6O*J(]RGL0R+DTT+4QYI56N?8?+*7M2=Z9G(=BD(IP-(:$R+C!3O,Q2$4P@UP MSEJ:)$ZOFG]JK)D5,'&*YY:FB$:F;,T_K3P*:15R';BEQ4C+3 ,4:DMC2E,* M5/D8IN,U:;,)E8Q9INPK5Y5%,DCK2,FCG<;LIG-(%)-3&/FG*O-7[1EQIC!& M<4UH35Y$XIQ04W5=C54T930D4Z.,YJZZ"FHN#4^U9+@/BBJRL?%-C8 5,'&* MER%R6*\D55F7%77D6JLA!K*[N7;0B')IXCR*:HYJRI&*I.QG*!7,=1-#FKO% M)M%:TYZD*GJ5$BQ4X'%/(%)70YE*:I%29%<[9L]")UXJI*,&KS$8JI*N:#&3&1/@UL6,V"*Q M I!J_:-@BNBDS*>J.UL)L@5T5K\P%<;ILO(YKL-/.5%>QA5<\3&1Y315:?LI MRCBG5Z\(Z'D.1'LHV5)2U7**XS;2'BI,<5&XHY$*X T\5$HJ44)#1G K0N[?8Q.*S6X M;%>'5/HZ+5AP/-6(Q5=15A#@5QR=CH5A[-MIGG$TV1JB7K7/)ARZDS-Q4#L: MFQD4QDI)LWBD1;C3UA2B/(S4;#% >E^]4IA)$1D(I?..*>8LU&T=,R(VF- M*C%J:8\U-%'BF N,"FAR#4Y3BHBG-2V.Q(IS2DTU>*=BJA+4M)#.:39,D-9JA)YJ9UXJ''-"9 !C4@?BA8\T[ M9BFF-$+N:8CG-/=*:J:;925ARL:DW4[RL"HR,5FQ-B[J-NZF5(#3B92(V3%.B.TTCM48?!KHAN9M' M0:=+\XKNM*;*"O-K"?$@KN](N/E7FO9PK/(QT&T=2O2@FH(I-PJ?K7KQ>AX; M5F-!YIX-,Q2%L"G>PF2YIIP:K--CO0LV>]/F%8L@4ZH5DSWI6? IKYJ92+Y+%A30348.*7.:%,5AE-IU2V-,K2KD5A:A%D&NB<<5CWT>0:XZ^J.[#2M M(X;4XPN[BN:E/[RNOU>/ :N0G&)C7C58GT%&=T2Q]*D)Q4QLB9>E!Q2#I32:5BT(PS0.*4IHQ25<1[DJTZHT-.8\5=QI"DTTU'NYIXHO:I":N12C+4U0:FQFEVUHF2D(M/[4@&*#3 MYAL0BFXIU&*&S/EN IKYI](16;9HE8C7.:ESQ3,8HS4V-(L:^:CYJQMR*:5H M-5(8,U,E-"T[I2L3)DV1BHFYIF\TH.:JQDPQ4B\4RES0(E)&*B)&:1FJ//-2 MT5$E%.!IB]*":21:$DYJ)1S4HYI2M:I@V*IXH-1YYIPIO4ABYI":0T#FLG$< M6 J3C%)BFDTBT!ZTY33*3-4D-LE)IAIH-.HDC)C>]2+3<4HJ+7(L.)H!J,FA M35J.AI$E-,:ESQ33UH1HF-[U*AQ30*0G%*UR9,DM6AW)ATI":3/%,)YIIDB,,FIH<"HP,T_.*38, ML.1MJJ_6G%S3&H(&YI149ZT]*I$V&O4)JPPJ(BM8/436A-:,5D%=CI5T %&: MXN+Y6K9L;DJP&:]3#2L>9B8W1Z-93;P.:U%/%IXKD-WKB8[]L]36Q87FXCFA3,IT;(ZI3D4[-58904'-3> M:/6M5,Y&B:BHQ(*<&S6RD2.HS3329K2+"P^EJ/>!2>:/6FV%B0TF:9Y@/>FL M]9N0TB3=2YJONYIX:ESC<26F&DWBC<*5P2%%/!XJ+(I=XI\P-$E%1^8/6D\T M>M+FL*Q-140D![TI;BGSA8?FC-1;J7=1SW'RDN:::9O%'FKZU2D*PHIX-1^8 MOK2[Q57#M:*=Q6)*,U'Y@]: M-XI\P)$F:,U'NHWBJ4@L245'Y@]:-XI\PK$@HS30:":+A8":B=]HS3LU3O7V MQDU+9:0/?*IQFE6X$G0UR-Y?LLV,]ZU-,N3(!FHYBU$Z)#4XZ55C;BI@XH4R M)(EIO%,,H]:C,P]:;G8E(L9HS4*R T,]-2'RDH:G"JZMS4RGBK3%)6'T4PN! M1Y@]:+DV'T4SS!ZTTR"J ?FBH]W-/%,30M+24M D+1112*"BBB@ HHHH *** M* $I,4ZB@5AN*7M0::34L:0C=*S[E-P-7CS4$JY%#AN*XJ[AV MRFO1]4AW*U<3J%OM8G%>576I[.&J&0#BG?>J"5]KXJQ!\U<,XGKTY"A*>%Q4 MA7%-S7-)'2A,4F*=32:R90=*0\T9HH1+8W;3A1139-[BXH-&:#S18=AN,T;: M=2YH&AN*3;3J,U((0#%!&:,TH--!<;MI:=FDIL&&*#1FDS4A80C-&VG4N:=@ M0VDVTZE!H0(0#%!YH)I* OJ)MI:=FDI@PH-&:0FI"PF,T;:6G9JD"&CBG4E& M:+BL(W%-!S2LIH 4#%+2TF:5M1B8IIIV:*&0T,* M4=*?GBF-S5(=@ZTTK2CBE)XJHO4F1$#@U]2*N@Y6HRN35M MG$CFKS2S)DXK$N-+*'I7H+1*5Z5B:A$HSQ3>Q<):V.-^Q$'I5FWLLMTJ\X4& MK%GM+BL+G6K)!%IN4Z5'-IQ SBNFMXU,?2H;J-0AXJ[$1J.YQ=PGDFK.G7.& M'-1:N=I-4+"7]X*S;LS=ZQ.ZBN\1CFD-_@]:R8I"8QS3&+9K12..4$;\=]GO M6A!/O[UR*7!0]:VK&YSCFMHR,I0-\J[7BA.M9MQ?C/6JDI%J!N>?47FJ5S?J MN1FKND9I.Y+/=;.]9\NI[>]4[B\WYP:S9=TG3--2-5!&W%JNYL9K3@N]_>N- MC1XVR] M1SW8QUK,GN=W0UDYF\*=T73??-C-31W.[O6!EBV:N02[>II>T*]F;R'-2%MM M9L5V .M)-?J!UJU/0S<':P+O5=K]:==3$H> M:YF^9C)UK+G-(P.LL=2W]ZTVN=R]:X[2RV1R:W]^$J74+Y">0[ZB2VRX-1B8 M9JW#.N14*0W'0U;*/8!5QVP*I03C;45S?*@ZU3D8J M4ES[U2EF)[U:D+D-,7_/6K,5UN[US@9MU7;>4@]:I2$XHZ2*3=4_6LZT?H_[1R>M8A=F[T MF MIYKC5-'30WN>]7HY=]\&W MK6KD<[BVQ)[O8>M5CJ'O69=W66/-4S,3WI*1HH:&X=1]Z?%?[SUKG&D;UJS9 MN2_6M.8EP1UD+[A5M*S[/[HJ^O%6F9-#Z*,TM5*D Q2$5A-%Q9CWT6X&N1U:WP"<5W5S'D&N M9U>#Y#Q7G5X7/1PTSS2]RLWXU>L.0*CU*#$QX[TZT.P5YU16/=I.Z+LW JJ# MS4SMN%0=ZXY'=!:$F>*C)YI:?VINW%)FFT4#&@4N,T8 MQ0)@::#S3\4;:$"%IA-/I-N:2&-%!Z4N,48H)ZC0:D[4FVEIE#&H%.QFC&*& M)B'I30:=BEVT($*.E,8T^DVYI(8T:D%- MVT[I3*$:F=ZD/-)MH ;BDS3\4FVA"0Y>E(U*.*0C- [C >:D[4FVEI,!A/- MIVVFGBJ0F(W%-'6G=:4+31+&L/EJHQ(>KV,U$T.>:ZZ,K'/45R[87)4BNRTF MYW;>:X%#Y;"NHT6XRR\UZ,)GEXF&AZ#"V8Q4F*I6DF8Q5U>E;IW/%DK,5ON& ML'46ZUN2'Y#7.:F^,UKT""U,69N34UBQ\P?6JI^9JOV,?S@U*B=#>ATUK_JJ MAO#\IJ>VXBJO=_=-6UH13W.*UDG)K,L,^96OJR98U6TRVW2#BLG'4Z'*R-NU M0E!Q5AX3LSBK]I9?NQQ5F2T^3I5K^GS$8IUY:?,>*BA7RZ:= MC2*N;1NL+UK.N[WY3S56XNMJ]:RI;LNV,T_:&T::'R7+-+C-:EFH=036*B;F MS6I;R^6M)3*G#0FNL1CBJL=T0W6J]]=$]ZIV\I9Z39"CH;=&:D63R*MI" M2F$+4;OM6H;-=T86K2&('%9NG7CF?&3UJ M]JO[S-9UA#MFS[U%RU'0[%+@_9L^U<_?WK"0@'O6NI_T?%8-W'NE_&ALCD%@ ME:0]ZV+6WWXR*JZ?9[L<5T=M:[ .*I7,Y.QE7MKLCR!VKG))'CF[UWES;>8F M,5S]WI>"6Q5!&2*]G>, ,FM%;PD=:Q''DMBIX9O>L7,V44CIT *YJ-Y@G>F1R_NI&7=5J8G!$L%VY?O6[93EL5@00_-6Y9IC%7&9C.)OVWS 58;@ M56M3@"K3YDWTA -8,DI+UMZD, US_ -Z7%3*9O!"R99*R;B++]*Z- M;?='5&>VP_2LG(U2(=/BQCBM20$+2V%MTXJ_/;?)TJ;L.9)V,%W8-3HYV#5/ M+;_-47D[:3F:J-S0AN3LZUFZC=MSBE\S9Q3?)^T41DR912*5I*\DG.:W4AS' MG%16NF[#G%;$=O\ )C%;(Q;1BO&0>E*"RULM9;NU1/8X'2M+:$28BF)+ MN/6FZ@/*S6?;W&9,4!N;07(IT8(<4ZU&]16E#:9.<5<$9R=BU89P,UJ=JJ01 M;*M=JT,6-8UG7_\ JS5]S6=>G*&DS2".1O1^]_&KEB2%J*[3,OXU9M(\+6#. MF)7U&=E4UBQ3,\OXUL:E'E36;9P;IOQJ&-Z&E!$67.*F,! Z5J6=EF,<58>R M^4\46(51'+RDH:L6EP,TDC82J); M<^*?-<'!!([.:?&C'M5VVL_,P<5?33\=JN)C)I&*T3>E6K&,[QQ6I]@SVJ>" MQV'.*U1C*1?LUP@JT:BA7:N*FQFM$9"BG4T"G52)8M%%%6(**** "BBB@ HH MHH **** "DQ1FEI- )333J2LI(9!*N:P]4AS&>*Z$C-9NHQ9C-7ZK!B0\=ZS =E=1J]O\Q.*Y>Y!0FO+K4SZ'#SNAXES06S5-7.:G4FO/FK'J MP>A*#S3P:C%&:Y9%DN:2D!HJ;D,6E%,%.IH28[--;FFYIZU98@XI2>*&I@ZT M &.:D6@#B@TF)BFDH'2D:IOJ%@)IG>CFEQ57!L:2)1)UHIJTIZ4=2K"[N*2F9-.IL3' T9S49ZTY:.@#J,TAZ4S)H M0]A]*#3::>M)$HDSFCI35I3THZE6%S24S)IPIL3'BD-)12%<*7/%---R::&A M^:4&FTTTD)$FE#W*L&:2F9-.IL3' T9S3#2K1T!#J,T'I4>320[#\ MTN::.E--")ZDFE#*L&:3-,).:<*;$QP-&H_.:*8O6GT,JP9I,TPDTX=*;$QP-&:.@(?1F@]*C) MI(=A^:7-,%!H)ZC\T4P4^AE6#-)FF$\THIB8_-&:8:!UHZ A]&:.U1DG-)#L M2=:!2+2]J!6%-)0*4T]PW$SQ33S2$\TY>:8Q@&*=FE88I@H$T/%2\;:B%*3Q M6].1C*)5G;#5K:/<;77FL2X/-3V,Q1A77"1Q5H71Z?I]V"BC-;D+[EK@M*O# MQS78V4P:,A26A1O0<&LE4)EK?NX\J:SHX?WO3O67,=21:MH,KTJR;BQC:N173(HQ7/Z2N *W@V%K1'+45V)-(L8K M/EOT!QD5'J=P54X-OYN,T.00IW.F>[5N]5Y'W#BLB"9WQUK2B5F'-9-G M7%)&==IG-06J8DJ_=I@56M\;ZCF-+&G_ ,L:RYAF7\:U#_JJR9G E_&G;FK4*;\9K5M;4<'%8VN:2T' MQPGR<5EW=DS-T-=3%;_+C%.-BK=15J)@ZECDX+%E[&K1@*CI70_854=*I74( M04[ JES/@3YJV+6/I67#CS*W;0# JHHB;+T"X%63TID0&**].OX,*3 MRMAIM&VD!IV:8,*7K249Q02%&,TF:,T@#;1BES10P8FW-+C%&:3-/H O6 MDVT9I=6I)H[M'WQ_A7.ZN<$UK M64V^+\*SM3B+YKT8VL>,XVF8EL_SUT5@_2L**W*MTK:L1@BMH/4<]CH8S^[K M/O'P#5Z/_55EWS=:Z'L80=F8-\_)J;2CF055NAN-7-*CPXI114Y:'86W^J%- MNO\ 5&GVW^K%-N_]4:G?:0>];LPC?J-N_N&N>E'[_P#&MNXERM8[C,OXU-C1;&YI M:_**TY6VK6?IO"BK\R[A5I'._B,+4I-P-<[Y>^:NCOX3@UBA=LM#1O%Z&I8V M8('%;$=H%6LVTNE1>M6VU-0N,BE9&W(<'FJ=H?WV?>IY3H3LCI+>+]Q^%9=Z MF)*V;=QY'X5D7S?/2E$49.Y>TL=*TKQL1_A6+87 3O5N[N@R=:$M#-OWBBTF M9:L8W1UG!LRUI0\KBLY1.I25C*NH,MG%3V1\HBK[VN_G%5)8O*IQC8SE-/0V M[6YR ,UIQN"M_%$$!+@U)I MT.KTZ3>!6RJ\5BZ7&5 K<'2M5L<\GJ4[O[IKGKP\FNCN1D5A7<).:EE09@R? M?J]:3;14$T)#=*$!6H9T75B>ZEWBH[(?O!]:8_-6+%/G%")9TUG_ *L59M;[/E>E M5I8-O.*SY3=R+-I/LP,UM6\^[O7)F?RVZU?M=0 [UI%&,XJQU.\8HW UC#41 MCK3EU$9ZUHC#E-:C)YK*2+12N MH\H:Y/5+7)/%=K*F5-8=_;9!XKBK0.[#5+,\[O(=A/%9F?FKI=6@VYXKF7X< MUY%:)[]"I=$H-.%1I4RBO.J1.^+'+3J *7%<[18T4IH(IN:I($AIH%/VTTC% M:(:$-*O6D S4FVA@Q>U1MUI]&W-(0P4&G8HQ2ZD]1@SFI*3;2T,JXQNM I^W M-)C%/H)C32#K3\4;:$"%IC=:?1C-)#N,%*>E+C%&*.I/48,YJ2DVTM#*&-UH M%/QFDQBGT$QIZ4@SFGXHVT($*.E,;K3Z,9I(=Q@I32XQ1B@GJ,&:D'2DVTM# M*&-2"I,9I,8I]!,0]*;S3\4;:$"%'2F-3Z,9I+<=QBTIZ4N,48JKDO<9S4@Z M4FVEJ64-:D%/QFDQBFA,0TWFGXHVTP0#I2-3NE&,U*W':?BC;0A(!TI&IW2C&:74=R,=:=2[:,4V2QG-/' M2C;2]*&4-:D'6GXS0%HZ &.*C.*-M+TH90UJ:,YJ3&:3;0M@$IO-/Q1MH0D"]*1J=C%&,TNH[D:U**3;3J; M8#:448I.E A&Z4SFI.M)MH& IP-,Z4W=S2N)%I4!%0S1@5+$V:649%:QD3)& M?G::OV-R5D'-4I1BHX9=L@KKI2.2K&Z/2-*N@4'-:$JB45QVF7V-HS75V4OF M@5Z-.=SQ*U/EE>E=FZ.;9G+/ Q/2M#3X"K#BM(V ]*G@M-AZ52B)LMP#""FW/,9J4 M#"U')R,5,A(Y74("SGBBRMR.U;4UIO/2EBM-G:N:<+G1&=BN8OEZ53GB..E; M?D\5#);9'2L73-HUK')W,3#.!63,TJMQFNUFL-W:J;Z.&/W:48-,;JHP+-Y3 MC.:UXR^!5N+20G\-74LL=JU460YHRW5BO2JOD,7Z5T?V+CI318<]*T4"'4*] MBA4"M4)D4V&VV]JM!,57(9N9CWT&5/%(^U6H MF;J(?96XVC(JZULN.E.A38*GZBM5 Q:#Q63 M)HP9B=M)TRXU#D%DF'K4\Q,6/%=8MEA<8JO+IH8]*'3'[1')Q+(O:I6$C#I70_V6!VIP MTSVJ>07.CG(X6W=*U+:(Y'%:2Z:!VJ>.SVGI4.D/V@R*W!7D5EZE;D9P*Z2. M+ JM=6GF9XI^ST(4]3AF616Z4H>45TDFEC)XJ+^S.>E3R-&O,F86^7WI#YA[ M&NB72@>U/_LD?W:M1)YTCEF:4>M,W2MUS74/I(_NU&-) /W::3#F1A00NS1Q5R+30IZ5I06FWM5VYZ55-N1VKI&M=W:HC8CTJ7 ?.<[Y!]*NV4VC,C2$;.E5KJW^0X%:RQ\4DD&]<8J5 OVAP=]&XM==<:4)#]VH M!I '\--Q%[2Y@[Y?>G*\OO6^NE#TIQTH ?=IQB+F1B+))[U(C2%AUK4_L_!Z M5/%IPSTK1(4F%@6XS6Y'T%58+79VJZJX%:)&38\4M(*6FC,****8!1110 44 M44 %%%% !1110 E%+10*PTBF8YJ6DQ2:*3(R.*HW,.Y3Q6CBHY$!!KFJ1N:0 ME9G!ZS:YW<5QMS!L<\5Z9JEMN!XKBM2M=I;BO(Q$;,]O"U=#GPV&Q5F,YJI( M"LE6(37FU(GK4YW+(6FM\M2IR*AFKE<3JB[C-V:6H5)W5..E27L)NQ2'FFL# MFE7WJS-R%'%/W4PFD'6@=Q]+NI.U,/6BPD29S1TIJTK5/4JPNZDS3.:=39+' M;J,YJ,YIRT/8H=THW4AZ4SFA /S2[J;33G-)$HDSFCI35I3THZE6%W4F:9S3 MJ;$QVZC.:C.M)$HDSFCI35I31U*L+NI,TS MFG=J;$QVZC.:C-.6CH"'4;J0]*9S20[#\TN:;3302B3.:*:M./2A[E6#=29I MG-.IL3'9Q1G-1FG+1T!#J-U!J/FDACZ7.*:.E(U58E;C\YHIJ]:<>E(JP;J3 M-,.E1'K4W:HV%3N.P^-\5(7R*J9(J16)K M2)#"56XYKL='O1@?7H\QZ9!.'45<49%6/2I\4PBCV97-K#8H[4G%/;I47.:M M0(2'@5(!34%25:B2V)M!I#&*=2U:6A)'Y8]*/+'I3Z6IY1W&;!2XIU%5RBN- MQ2%!3Z*:0$!B'I2K&/2I<48I6*N-\L4NP4ZBG8D3:*38*=118"/8* @I]%1; M4=QNP>E)M%24E-H+C0*0@4^F-2L-$3(#3!$,]*G I0M0T5>PQ8QZ4_8*=BEH M426R)HQ3/*'I4^*,4[:C3(A&*D"@4N*6K0FPQ12TE,D0BF[:?1BE8=QH6EVB MEHI@-VB@J*=12L%R/;3@*=BBAH=QI45&RBIJ:12Y03(0O-2!: *>!0XC;&[! M3#$/2IJ,4N45R%8Q2M&,=*EQ156L%RF81GI4\<8%2;:4"FD#E<,"EHHJB0HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** $IK#BGTT]*SFM!HS;N#> M#Q7)ZO9X#<5V\BY%8>IVV]3Q7G5H)G;AZEF>87D.V4\5 IVFN@U*QVL3BNM&<4@L&,44;J3-#!B[:3%+NHZTV#$ MQ2[:,XHW4 %&VDI=U) A,48S2]:,XHZA;40C%-S3BM F M)BEVT=*-U (*",BDI=W%"0)D3+0@IY&::?EI@T2CI3'Y%,WTX<3J]-O>1S75V=UN4QAS74Z=J&<#->C1F> M7B*5SMXGW"IQ679S[E'-:*/FO3IR/'J1:9,*=35-.KKBS!BT44E:6$+12446 M%<6DHS29HL%QU-Q2YI:+#3&@4N*6BE8!*6BBBP!1113L 44446 *813Z832: M *;(F13@:=4V'SA:M MSF8"5ZUH1G=5.5/+-6+0Y(K@G&S/;IST++)Q4!]E&VJD@P:QDC=2N(KX% M(?FJ(M@U+'S47,VP"TM/*\4RH:*0&F'-/I=M%RD,%!IV*,5(=1@SFI*-M%#* MN,;.:!3\9I,4^@F-/2D&HP9S4E& MVBAE7&-UH%/QFDQBGT$QIZ4@S3\4NVA @'2F-UI]&,TD.XP4II<48H)ZC!FI M!THVT4,JXQJ5:=C-*!BGT 0]*CYS4N*0K20 #Q3&H)I0,TTAC13J=BDQ29#W M&M+MHZ4%"-3!G-2=:-M,0G:F$\T\]*C/6AB1*@S3)1Q4L M0I9%R*=]!W*(SNJ>,TUDP:1#\U2F3)7+8&15*Y4BM"+E:@N(\UI&1E)&;&[* M:V],NB'&36.R8-3VLFQJ[*4CDJPNCT?3;L%!S6[!+N[UP&GWV"!FNLL+D,!S M7IT:ESR,11L= C5,#5*.0591LUZ5-GFSB2TE+3372C!BT44E!(&DHI0*8MP% M.% %+2+2"BBBD4%%%% !1124 +124M DQ#TJ-JEII6@8Q:D%(!3J $Q2;:=1 M0 @%+110 E)3J2@304M-I:8)BT444AA1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 44E)0)L=124M PHHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH ***0T %%)1VH:)N-8TS=FE>F#.:YYHM$%VFY#7):I M9[MW%=G(,K63>VX9#Q7)4A<[<-/E9YCJ%MM8\52A;RS74ZM9\MQ7+W$9C)KS M:M/4]ZC4NBX+@%<9J.0Y%4(Y3NQFK@.4KCG&QV1D5G;YJM0'(JJZ'=5F#Y16 M#0RPYXJ$GFGNV147>LV:Q6@ZEW4E-YJ44B3.:,XIJTK4=1V#=1FFPQU)NH/2FE)[CL&ZDS3.:= M38F+NQ2YS49IRT= 0ZD+4IZ5'S20P/-.!Q24AIBN29S135IQZ4GN.PFZC-,/ M6G"FQ,7-+G-,-"T= 0^DW4IZ5&M) /S1G%-%!H)ZC]V:*8O6GT,JPFZC-, M/6E%,3'9I=U,- ZT= 0^C=1VJ,YS20[#\T9Q31TH-'4GJ/W45&.M2=J&58-U M)FF'K2BGT$QV<4N[-,- ZT($//2HCUJ7/%,9>:8#XVJ1FXJ <4NC09PUZ=STZTOMX'-;$$N0*X32[LG'-==92[@*] M.G(\>M2L;2G(HIL9RM/KMBSSI(;3:<:;6ABQ13A313A0QQ%I:04M2:A1110 M4444 )24M IDB4M%)0&PZBDI:104444 %%%(: &DT TUJ%JK 2T4@I:D!*** M6@5@HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)2TE ,*2BEID[A M2T44B@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** $I*6DIDL3&::5Q4E(142142$U#-%N0U9(IK#BL)1-8RLI3GM'2@.H8HI-V:6DP88I,8HW8I.*[;3HMH6O4HGD8BUCHH#\@J:H(>$%35WQ9Y$ MMPQ3<4[-)5W,VD(!3J**&P2%HIF:<#2N786BBBF(**** $HI:* "DI:* "BB MB@ HHHH ****+@-(H IU%.X!1124A-A13:<*8DQ:***104444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 )2T44 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4AI:* &TM%+3%8****0QI%1M4K5$U M93*B02("*Q;^T#@\5O$9J&2 ..EK68"M M@5P>IPE7/%>=6I6/6P]?F,TRX-2H=U9TA8/5VU.>M<$X6/1ISN6=M)4IQBHS M7)-:G9%B4P@T^EQ4(M#!3J4BDH$PHHHH:$,-*M.Q1BJ0VQ#31UJ3%!% T&>* M8>M&:E I)#L, IU.(I*&9]1F#4@Z48HH95QC4@I^*3%/H2V%-P:?2X MH0T(.E(U.HQFDMQW(Q3J=BDH9+&8.:>.E+BBAE7&M30.:DQFC%/H(;3>]/I< M4K@A!TI&IU'6A#N,4'-//2EQ2T,9"0E+BBFQ#6IH'-28S1BCH VFT^C% M")O804C4ZBGV\QAQ69!N,H%==I-IO"Y%=]"&IPUZED7=,M-N.*ZF MUBV@<55L[0*!Q6O%'@5Z=.!XM>KM.6DRF.HHHHN0%+1132 ****8!1110 4E+128"4M%%%@$I:* M*$@"BBBF E)3J3% FA*444M,$@HHHI#"BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@!#3"*DIN*B8TQFV@BGTTUBT.YFWT M/F*>*Y+4M*W9.VN[=,U0O+92AXKEJPN=-*HXGE%[II1B<50SY)KN=4LQ\V!7 M'ZA:L&.!7#5I:'KT:I%'<;N]3YXK.B1D/-70W%>95CJ>K2G="EL&@24P@F@* M/Y>M M582=R0C%1,U2,X(J$CFBQJ@IX/%-I<4%V FDSBEIII6'T';LT;::!S4G:D0- MSBG9S3&ZTJTF X\4W=2MTJ/'-3<+$M)NQ2CI4;#FBX6) V:":8M./2D,3=S1 MBF8YJ0=*8"]*:3FE-,IW*%!YIV:93@*8-"XHSBEIC4R1P.:6FK3CTI"$W44S M'-.%,3%S29H- I,S%S1NI#TIG>A&B),TF<4#I332%U'YS2TU13CTH95A-U&: M813A38F+G%&&R:6HU'-/H98F MZC.:81S3ATJB6+G%&[---(!0'0?29I:;00QU&:!2&BP"YHI!UI: 0;J7K4>. M:D6@T$/%*&I&IHX-($2$\5&7YIQ/%0,#FI121*#FEZ4D8IY%#8" TZF8(HSQ M47!B[J>A8$V:E2/S*I0*6-; MMA:EB.*[:=,YISL@L]-W2 XKLM*LMBKQ4&GV0P.*Z*T@"@<5Z-&D>5B:Q-#% M@"K:KBA5Q3\5WQC8\J4KA3<4ZEJ[&;$ I:**:0!2&EI*3 ;BE%+BBACN%+24 MM"0@HHHJ@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I M*6DJ6 4E+25FT,:14$Z96K-,=*Y?4+#.>*[R>#<#Q61 M=V.X'BN2I$[Z56QYQE3F?BJ\GSU:948D2.2:L8XJ%4Q4H-%S5(:>M.%%-SBIN-L4T@HSFC.*=Q M7'8IM&[-+BI&A0,T4W.*7.:"9!2XI*3=4V$AU&*;FC- (=BBFYS1FA ]QV*; M1NI<55BT I"*,XHZTK!<%%28XIN,4;J8QI/-*!2XIN<4"8ZBDSFEI$!CBDI- MU.IL&A**0G%)FCH38=1BBEH0"4N*,4A.*DI(7%%-!S3J 88XI*-U+5,& %&* M0G%)NS0 ZC'%)FDW4($+2@44A.*06%Q13=V:7-#!CL4E-W4[K38 !012$XHW M9HZ %%!IN>:$)H?12#F@\4[BL%%(#FG4F-(,4ZF;J4'-#*0III%*3BF;LU(Q M:-N:2EW4,=QP&*D S35YIW2DR;B.,"JY/-3LV:A(I)!<=6IW/3P]:QPTB%*J.W M-;%];E6/%8TJ$-TKSYTM3U:=0FB.:L!E-Q4E)BF),2FD5)28I6%<:*4TN*6BP7( MP.:D'2DQ2BBP[C6%"BGXI#0,4TS'-.H/2D4F&>*8W-!/-*.:8@44X]*=BDJ' MN,BQS3QTI<4E%Q,1A2 4_%&*=PW$Q13J*5Q6"F,*=1BF@N-44X]*7%%#*(L< MT\=*7%%*XF-84T"I *"*H0VFXI]+BE<$(.E(PIU YH0[D8%.IQ%)0R6,Q3QT MI<44KE#6I%'-/I<570$)CBHR.:EH(J;C&"AN:#2CFF.PT#FG=J4BFT;A8;CF MGBE I*39+$;FF@4_K2XI -[4SO3Z,47N3>P]#BG,_2HP<4,] M:1IBDRO.:H'):K\@W5%%;EI.E=-.!QU)CK6W9F%=;I5G]W(JEIUCDKD5UVG6 M@7'%=].!YU>I9%JUM0 .*U(H@HZ4L40 %3[<"O0IQL>34J6V\'BM@BH9(\USSIW-H3LSA]0TW.3BN8O;+83Q7IEW;!E/%*3I4I(-1,*Y9JQT18;Z3=FFX-*!6#9H+BEZ49I*1$AV*"<4JCBFL*I"L*&S3C3 , M4XT,!I:C--(YIPH$QP-+UIM**+B0&F;J>:CQS4EC@:<#3 .*=3('9S2&@4&A ML:&;J4&FDE;P@83J618MX_-/2MRRTS<0<5#IU@<@XKK["T 4<5TPIGF5ZQ%8Z=MQQ6[; M0;.U/@A '2K2KBNVG"QY56LV.48%.HI:Z8HY;C=M. I:6NB*$V%%%%6(**** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH *2EHJ6@$HI:2DT,2D.#2,<4P-S2Y2DAL MD885F75F&4\5L=14,B9%93@:0FTSA=3L>N!7+7=J5)XKTV[LM^>*YK4--QGB MN&K ]2A76QP;*RM3TD(-:5W9[&/%9M.%)BCI4-%;CJ*0&@G%)"'4VF[J4&M$ M0Q:0T9HJT9MA3L4E+FJO8$%%%,)I%6'T4T&G4 %)114M@%%)FC-'00X4_'%, M%+NI Q#12&FEL4F5$?24T-FES0-[CL"EIFZG"AHH6FF@G%(.:0T IX%-Z4FZ MK0F24E(#2%L4EN II*3=FE%#(8N*2ES12'N HII.*0-F@=M!U+@4W-)NH$AU M**04A.* L.)I*;NS2BI8,=BDQ0#2TTPW"D-(3BD#9IE(4=:D IF*7.*I:E"D M4VG]:8W%78?,)12#DT[%2T)M"XI"*3-*.:S:(8E%#<4S-385B05* ,5"*?NH M$(XI@IQ.:2K6Q-@IRTE**J(R=<8IK&HO,Q33)FMD(<33&II:D#9K2)$F,:H\ M$FK03-2QV^6Z5TTXF%2=BO% 6/2MW3[')&13[*PW8XKI+*PVXXKMA3N>?6K6 M'V5B !Q6[;P!13+>#:!Q5Y$P*ZX4['DUJMQ47%28H%+70D*W"*B>$-7+.F7"HTS@;_32<\5S5 MWIY5CQ7J-W9J0>*YV^T\<\5PU:1Z="N>?O 4-.2396U>V1&<"L&YB=3P*\VI M3U/2IUBQYP:@#-4H2V>:O(PQ7).!Z%.H/'2FD4[<*7(KG<3>,A@XH-*:05/* M6- IPIV*2FC.0A% I:*HBPM% I31N4D-II&:4]:<*=R^6PT"G4M%2V383%)2 MDTE2V#0F,T8IXH(HN9]1M%)BE[4TRA*:13J: ,4X4&BP[B'I3<4M.[4;"8@Z4A&:=0!2%U-Q3Z7% D(.E(PI314W'<8!S3A3C3:&)BXI>U%(: V& ML,T@'-/'-+BFAW#M28I:7C%7$$Q <4AYI#2K6B!B 8IW:E(IO>DQI#2.:<.* M7C%-)%0P2!N::%YIP.:?BH!C,4N*=BDI6%82E I*D052)8W;2$5,1Q43G%:Q MB(KM49?%/=A59CSQ6T8F;E8FW9J1144*%JO);L1TK6,-3*4QT"[CBMJSL"Y! MQ5*RM6,@XKM-*LQM7(KT*-.YY>)KV([*QVXXK;A@P!Q4T=LJ]JL*@%=\*=CR MJE9L1$P*E H I:Z%$YF[A2T45<8DBT44E:H04M-I:!)BT444#"BBB@ HHHH M*2EHI6 ****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4AI:* &XI12T4 )2&EI*SD@N12 M)N%9US:!@>*UL4QU!%82AZ7U^6O0IX 0>*Q[NSSGBN& MI2/0HUCSBXM?))XJCYI#8KL-1T_.>*YR;3RK]*X:E(].E6*ZR$U()*0P%*8> M*YI4SNC4+ .:=BJZR8J9'W5A*!NIZ#B:C)J;;D4PQUERE)W(]U/4YI/+H'%2 M[E6'TF:,T@%"*0[%(3BG9II&:FY0 T$T 4I&:FY+(]U*#2^7S1C%-DL4&GCF MHZ>O%2R;"D4SO3R>*C-" =BCI3=U+UJBK!FD)I<4F*I$B;J4#-&RG@8ILI,; MTH'-*12#BFB@(Q3=U.)INVFT2.'-+TH%%0(.M%'2B@ HHQ10 =*,T=:* "C- M%&*E@&*:3BG=J:PS3&A V:6F@*P M[K3N3\M=M);[NU4Y[$'M7-.E<[:>(L>>7-D1GBLJ>!E[5Z%=Z:,'BNE52S5-R]2QVY;M73&GAVUT*D<,ZQ!96&<96MRVT]1CY:LVMEMQQ6 MK#;X[5TTZ)PUL1H06]HJXXK12( =**E KJC2/-G4;$ Q3@*,4M=,(6,6P MQ2T45M804444P"BBB@ HHHH *2EI*!,#3:6D-,EL*6FTHIB3'4M(*6I+0444 M4#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH 0TE.I*8F@I**6@6XF*6EHI#L--)NI6J M+G-*PR448I%IU2X@)BF.@-24AJ' I,H3P!E/%8EYI^_/%=05!J)X%(Z5A*G< MVA5<3S^ZTHG/RUBW.E$9^6O2Y[-3VK)N;!3GY:XZM*QZ%'$'F\NGE">*K-$4 M-=M>:?UPM<_=63 ]*XY4STZ=8RE;%2K-BB2W9>U5V1A6$J9U1JEU9-].V9YJ MI 2#S5X.NVL)0-E4(MM+LS2EAFGJPK-Q'SD12FE:L$BF8J7$I2(L8-/!I2*9 M@UFXE)CLYHSB@"F-4V$/SF@)3$ZU:&,46' M*58S(:@BM9"_0UN65DQQD5TPI'/4K)$$%D3VK6MM-)QQ5^TL>GRUO6ED!CBN MNG2."M7T,VTTS;CY:V[:TVCI5Z&U4 <5:2(#M76J1Y4Z[((H<=JM(N*>% I< M5T*G9'+*=P%+116L49MA124M:6$F%%%%,5Q:***104444 %%%% !24M% F-I M*<:2F383%*!2XI:+C41*6BBD4%%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (:2 ME-%,EA2T44AA1110,0BF[:?10 @%+110 TTW/-.(IN*5BD.%!%***AH1"Z9J MI-;@YXJ^349YK&4$S2,FC"N+(-GBLFYTP'/%=:\6:JRVV1TKGG2.RG7:."NM M.QGBLF>SQVKO[BPW9XK)N-,Z_+7+.D=U/$(X62,Q]J@\]@<5T]YI9Y^6L>73 MBK=*YY4CKC6*BR$T\2D5)]F*]J88L5@Z9LJH]9,U(#5G.:@)YJ7$NZ+&>*C8T@:EQFH: M'<0/EKJC2,9UK%:!"]:<%AYF.*O6NDD8^6MNUT[;CBNJ%$YIXE6, MJWT8<';6I;Z8%Q\M;$-L !Q5I+<>E=5.D<53$,HP60':M&*#;VJ=(L=JE"UT MQIV.*=5L1!BI *3&*4&MXQ,'J.HHI:NQ(E)2FDJD0Q:2ES24P"EHI:0T@HHH MH&%%%% !1110 4444 )12T4 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1124 +1244"N+1244!<#29I&-,!YH&3"D- I:30$;4 MT"I"* *AQ*N-VTTQ@U+1BCD!2*K0 ]JJ2VJGM6H14;1YK*5,TC4:.;NK$'/% M8MQIO)^6NWDMPW:JLE@&[5S3HG5#$V. FTXCM5&6Q8=J]#ETP$=*R[G30,\5 MS2HG33Q%SA)+5AVJJT+"NPGT_KQ6;/8X[5BZ1UQJG/;2*4$BK\ML0>E5FA([ M5C*F=4*EP1Z?Y@JLV5J,N:Q<#>,KEMG!J,FH0Y-2"LI0-4QP/-3(:A%.#8K& M431,L4HJ%6S3]V*SL5)L8=EIO RM;,&GJ,?+6 MG#8!.U7([<#M73"@1VKO9; 'M6?/IV?X:Y94CNAB$<4;4KVIACQ733 M::>>*HR:E8RI,Z(XA,Q3Q32:U'TY_2H&L'':N>5)FRKHI;\4&6IGLW':H M?LKYK*5(M5AOF4HFI3;-BHS P-9JFS15$R3=NIXIB(1UJ7;0Z8G4%S248I:7 MLRE4#-'6F%J4,*GV;!5-1>E+FFDT9H]F#J:BXIT5AI;%,,N*>4)J-H6-4J9'M$-,],,V:#;/FG+:.:M4Q.JB/S*4/FIQ8N> MU2Q:>^>E7&D0ZR*RQEJF6V)[5IPZU8O#G0L4<<^G<=*JR6&.U=PVFY[5 ^E9_AJ'A6:QQ:. M$>U*]JB\AO2NVDT;/\-1?V)_LU#PK*^MHXXP-Z5$T3>E=J=$_P!FHVT+_9I? M5F'UM'$M$WH:9Y;>E=J=!/\ =IO]@'^[26&*^N(X]8V/8TXPMCI78+H)'\-. M.AE=A_8//W:<-"_P!FJ6%93QB.36%O2IE@;TKJ MET/_ &:E71U=,FD8_AJPFEX[5:PQ+Q:.673<_P MU8CTP?W:Z==-QVJ9;#':M%AR7BT<]%I(./EJ['I"X^[6[': =JLK .E:QH' M//$F%'I:CM5N/35]*U1"/2I5C [5LJ",)8AF>E@!VJ868]*O!12XJU21BZTB MFML!VJ94Q4V*3%:QII$.;>X@%.Q2@4M7RD-B44M%.PA*3%.HH2'<3%+115"" MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH *3%+118!-M(4%.HI-(=R,QCTI/*'I4M)4E3T4.*'S,@^S+Z4GV9/058HJ>1!S,K?94]!1]E3^Z*LT4O9H M.9E?[*G]T4GV9/059HH]F@YF5_LJ>@H^S)Z"K%%/D06/2I*6J4$+F8S8*-HI]%5RA=B;:,4M% M.PA,4M%%%@"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 ME+114H I***& 4444 +2444 %+110 E%%% !1110 4444 +1115( HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH 4H **** "BBB@ HHHH **** /_]D! end GRAPHIC 3 image00002.jpg begin 644 image00002.jpg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end GRAPHIC 4 image00003.jpg begin 644 image00003.jpg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